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1. General experimental information 
All manipulations were performed in oven-dried glassware in an atmosphere of air unless 
stated. All reagents and solvents were purchased from either Alfa Aesar, Fisher Scientific or 
Sigma Aldrich and used as supplied. Flash column chromatography was performed on silica 
gel (Fluorochem, silica gel 60 Å, particle size 40-63 µm). Thin layer chromatography was 
performed on glass-backed silica gel plates (2.5 x 7.5 cm; Merck, TLC silica gel 60 Å); 
compounds were visualised by exposure to UV light (254 nm) or using a permanganate 
stain. NMR spectra were recorded on a JEOL Eclipse 400 spectrometer at 298 K; chemical 
shifts are reported in parts per million and coupling constants are reported in Hz. For some 
compounds, assignments for 1H and 13C NMR peaks were aided by 1H-1H COSY, 1H-1H 
NOESY and 1H-13C HMQC 2D NMR experiments. FTIR spectra were recorded in a diamond 
ATR cell using a Perkin-Elmer Spectrum 2 instrument or an Aligent Technologies Cary 630 
instrument. Melting points were recorded on a Stuart SMP10 melting point apparatus and 
are uncorrected. High-resolution mass spectrometry was obtained from the EPSRC UK 
National Mass Spectrometry Facility at Swansea University on an LTQ Orbitrap XL 1, using 
positive electrospray ionisation (ESI+). HPLC was performed on a Waters Acquity UPLC 
instrument, in conjunction with a Waters Xevo-G2XS-QTOF for MS analysis, using a Restek 
Raptor C18 2.7 μm column with a gradient eluant from 0.1 % formic acid / 10% MeOH / H2O 
to 0.1 % formic acid / MeOH over 10 minutes at a flow rate of 0.25 mL/min. Induction 
coupled plasma – mass spectroscopy (ICP-MS) analysis of Ag and Pd content was 
performed using a NexION® 1000 (PerkinElmer®, UK) operating in He KED mode to 
minimise polyatomic interferences. Peak hopping scans were used with 50 ms dwell time for 
Ag 106.905 and Pd 105.903 (corrected for Cd) AMU with 40 sweeps per reading and 3 
replicate readings per sample. Calibration used external standards (10-1000 ppb) for Ag and 
Pd with the signal for In 114.904 AMU (20 ppb) as an internal standard. Concentration of 
samples and standards diluted in 1% low metal nitric acid (Sigma-Aldrich 225711) were 
determined from a calibration curve using a linear thru zero function.  
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2. General experimental procedures 
2.1. General procedure for the synthesis of dipeptides 
 
The amino methyl ester hydrochloride (2.50 mmol) and K2CO3 (0.498 g, 3.60 mmol) were 
dissolved in distilled water (30 mL) and stirred for 10 min at room temperature. The free 
amino ester was then extracted with Et2O (3 x 20 mL), unless the amino ester was L-
tryptophan methyl ester, which was extracted with CH2Cl2 (3 x 20 mL). The solution of the 
amino ester was then dried (MgSO4) and concentrated by rotary evaporation. The resulting 
oil was dissolved in CH2Cl2 (20 mL) and the appropriate N-acetyl amino acid (1.00 mmol), 
HBTU (0.379 g, 1.00 mmol) and i-Pr2NEt (0.174 mL, 1.00 mmol) were then added to the 
reaction mixture, which was stirred for 12 h. The resulting suspension was filtered and 
washed with 1 M HCl (20 mL), sat. NaHCO3 (3 x 20 mL) and H2O (20 mL). The organic 
layers were then dried (MgSO4), and concentrated to dryness in vacuo. The resulting oil was 
recrystallized from CH2Cl2 / hexanes. 
 
2.2. General procedure for the synthesis of tripeptides 
 
Lithium hydroxide monohydrate (0.101 g, 2.40 mmol) was dissolved in H2O (2 mL) and 
added to a solution of the appropriate dipeptide ester (0.80 mmol) in a 3:1 mixture of THF / 
MeOH (8 mL). The solution was then stirred at room temperature for 8 h, followed by 
concentration to dryness in vacuo. The resulting residue was then acidified by the dropwise 
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were combined, dried (MgSO4), and concentrated in vacuo to give the dipeptide acid as an 
oil. The crude dipeptide acid was subsequently used without further purification.  
The appropriate amino acid methyl ester hydrochloride (2.00 mmol) and K2CO3 (0.398 g, 
2.88 mmol) were dissolved in distilled water (30 mL) and stirred for 10 min at room 
temperature. The free amine was extracted with Et2O (3 x 20 mL), dried (MgSO4) and 
concentrated to dryness. The resulting residue was slurried in CH2Cl2 (20 mL), before the 
addition of the dipeptide acid (0.80 mmol), HBTU (0.303 g, 0.80 mmol) and i-Pr2NEt (0.139 
mL, 0.80 mmol). The resulting suspension was stirred for 16 h at room temperature. The 
suspension was then filtered and washed with 1M HCl (20 mL), sat. NaHCO3 (3 x 20 mL) 
and water (20 mL). The organic layers were then dried (MgSO4) and concentration to 
dryness in vacuo. The resulting solid was triturated in Et2O (15 mL) and filtered to afford the 
tripeptide as a solid. 
 
2.3. General procedure for the Boc protection of Trp residues 
 
The tryptophan containing peptide (0.75 mmol) was dissolved in CH2Cl2 (20 mL) and treated 
with NEt3 (0.105 mL, 0.75 mmol). A solution of Boc2O (0.327 g, 1.50 mmol) in CH2Cl2 (5 mL) 
was added dropwise to the peptide solution; the reaction mixture was then heated under 
reflux for 16 h. The solution was allowed to cool to room temperature, before concentration 
to dryness by rotary evaporation. The crude compound was purified by flash column 
chromatography and the resulting residue was recrystallised from CH2Cl2 / hexanes to afford 
the Boc-protected peptide. 
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2.4. General optimized procedure for the C-H olefination of Trp containing 
peptides 
 
The appropriate tryptophan containing peptide (0.238 mmol), Pd(OAc)2 (5 mg, 0.024 mmol, 
10 mol%), AgOAc (0.100 g, 0.599 mmol) and styrene or styrene derivative (0.952 mmol) 
were stirred in toluene (3 mL) at 100 °C for 2 h. The reaction mixture was then allowed to 
cool to room temperature, filtered through a plug of Celite, and concentrated to dryness. The 
resulting crude residue was purified by flash column chromatography and recrystallized from 
CH2Cl2 / hexanes. 
 
3. Detailed experimental procedures and analytical data 
3.1. Synthesis of Ac-Gly-Trp-OMe (1a) and Ac-Gly-Trp(Boc)-OMe (1b) 
Ac-Gly-Trp-OMe (1a) 
 
Peptide 1a was synthesised from L-tryptophan methyl ester hydrochloride (0.637 g, 2.50 
mmol) and N-acetylglycine (0.117 g, 1.00 mmol), using the procedure in section 2.1. The 
crude compound was recrystallised from CH2Cl2 / hexanes to afford 1a as an orange solid 
(0.279 g, 88%); m.p. 177-180 °C. 
1H NMR (400 MHz, CD3OD) δ 1.93 (3H, s, acetyl-CH3), 3.21 (1H, dd, J = 14.6, J = 7.4, Trp-
CHH), 3.26-3.31 (1H, m, Trp-CHH), 3.65 (3H, s, ester-CH3), 3.81 (2H, d, J = 4.1, Gly-CH2), 
4.74 (1H, app q, J = 7.4, Trp-α-CH), 6.99-7.03 (1H, m, Trp-Ar-H), 7.06-7.10 (2H, m, Trp-Ar-
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13C{1H} NMR (100 MHz, CD3OD) δ 22.4 (acetyl-CH3), 28.4 (Trp-CH2), 43.4 (Gly-CH2), 52.7 
(ester-CH3), 54.8 (Trp-α-CH), 110.3 (Ar-C), 112.3 (Ar-CH), 119.1 (Ar-CH), 119.9 (Ar-CH), 
122.5 (Ar-CH), 124.6 (Ar-CH), 128.7 (Ar-C), 138.0 (Ar-C), 171.4 (C=O), 173.7 (C=O), 173.8 
(C=O).  
IR Umax /cm-1 (solid) 3235 m (N-H), 3060 w (C-H), 2951 w (C-H), 1749 s (ester C=O), 1642 m 
(amide C=O), 1436 m (C-H).  
HRMS (ESI) [M+H+] m/z calcd. for C16H20N3O4: 318.1448, found: 318.1451.  
Ac-Gly-Trp(Boc)-OMe (1b) 
 
Peptide 1b was synthesised from Ac-Gly-Trp-OMe (1a) (0.238 g, 0.75 mmol) using the 
procedure in section 2.3. Purification by flash column chromatography (EtOAc) followed by 
recrystallisation from CH2Cl2 / hexanes gave 1b as an off-white solid (0.276 g, 88%); m.p. 
92-95 °C, Rf 0.16 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.66 (9H, s, Boc-(CH3)3), 1.96 (3H, s, acetyl-CH3), 3.19 (1H, 
dd, J = 14.6, J = 6.0, Trp-CHH), 3.27 (1H, dd, J = 14.6, J = 6.0, Trp-CHH), 3.69 (3H, s, ester-
CH3), 3.83-3.94 (2H, m, Gly-CH2), 4.90 (1H, dd, J = 7.8, J = 6.0, Trp-α-CH), 6.48 (1H, br t, J 
= 5.0, Gly-NH), 6.94 (1H, br d, J = 7.8, Trp-NH), 7.22 (1H, t, J = 7.7, Trp-Ar-H), 7.30 (1H, t, J 
= 6.9, Trp-Ar-H), 7.41 (1H, s, Trp-Ar-H), 7.47 (1H, d, J = 7.7, Trp-Ar-H), 8.08 (1H, br d, J = 
6.9, Trp-Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.8 (acetyl-CH3), 27.3 (Trp-CH2), 28.1 (Boc-(CH3)3), 43.1 
(Gly-CH2), 52.5 (ester-CH3), 52.6 (Trp-α-CH), 83.8 (Boc-C), 114.7 (Ar-C), 115.3 (Ar-C), 
118.6 (Ar-C), 122.6 (Ar-C), 124.2 (Ar-C), 124.6 (Ar-C), 130.3 (Ar-C), 135.2 (Ar-C), 149.5 
(C=O), 168.8 (C=O), 170.6 (C=O). 
IR Umax /cm-1 (solid) 3273 m (N-H), 3058 w (C-H), 2933 w (C-H), 1740 s (ester C=O), 1658 m 
(amide C=O), 1428 m (C-H), 1246 s (C-O).  











3.2. Synthesis of Ac-Phe(4-vinyl)-OMe (SI-3) 
 
Boc-Phe(4-vinyl)-OH (SI-1) 
Compound SI-1 was prepared using a previously reported procedure.S1 
 
The unnatural amino acid N-Boc-4-iodophenylalanine (0.391 g, 1.00 mmol), potassium vinyl 
trifluoroborate (0.161 g, 1.20 mmol), K2CO3 (0.691 g, 5.00 mmol) and Pd(dppf)Cl2 (0.008 g, 
0.01 mmol) were dissolved in H2O / i-PrOH (10 mL) and refluxed at 80 °C for 1 h. The 
reaction mixture was allowed to cool to room temperature before the organic solvent was 
removed in vacuo. The remaining aqueous solution was then acidified to pH 3 using 5N HCl 
(ca. 2.0 mL). The resulting aqueous solution was extracted using CH2Cl2 (4 x 25 mL) and the 
combined organics were dried (MgSO4), before the solvent was removed in vacuo. 
Purification by flash column chromatography (CH2Cl2 / MeOH / AcOH, 97:1:2) yielded SI-1 
as a brown oil (0.256 g, 88%); Rf 0.30 (CH2Cl2 / MeOH / AcOH 97:1:2). 
1H NMR (400 MHz, D6-DMSO) d 1.31 (9H, s, Boc-CH3), 2.81 (1H, dd, J = 13.7, 10.4, Phe-
CHH), 2.99 (1H, dd, J = 13.7, 4.5, Phe-CHH), 4.02-4.11 (1H, m, Phe-a-CH), 5.21 (1H, d, J = 
11.1, 0.6, alkene-CHH), 5.78 (1H, d, J = 17.7, 0.6, alkene-CHH), 6.69 (1H, dd, J = 17.7, 11.1, 
alkene-CH), 7.10 (1H, d, J = 8.5, NH), 7.22 (2H, d, J = 8.1, Ar-H), 7.38 (2H, d, J = 8.1, Ar-H). 
13C NMR (100 MHz, D6-DMSO) d 28.2 (Boc-(CH3)3), 36.2 (Phe-CH2), 55.2 (Phe-CH), 78.1 
(Boc-C), 113.7 (alkene-CH2), 126.0 (ArC), 129.4 (ArC), 135.3 (alkene-CH), 136.5 (4° ArC), 
137.9 (4° ArC), 155.5 (C=O), 173.6 (C=O). 
IR Umax /cm-1 (oil) 3442 m (N-H), 3027 w (C-H), 2958 w (C-H), 1729 s (C=O), 1534 s (C=C), 


















HRMS (ESI) [M+H+] m/z calcd. for C16H22NO4: 292.1549, found: 292.1551. 
The 1H and 13C NMR data match that previously reported.S1 
H-Phe(4-vinyl)-OMe (SI-2) 
 
The unnatural amino acid Boc-Phe(4-vinyl)-OH (SI-1) (0.256 g, 0.88 mmol) was dissolved in 
ice cold MeOH (10 mL) and treated with the dropwise addition of thionyl chloride (0.290 mL, 
4.00 mmol). The solution was allowed to warm to room temperature before refluxing for 4 h. 
The volatiles were removed in vacuo, and the residue was dissolved in toluene and 
concentrated to dryness three times. The resulting material was slurried in sat. aqueous 
NaHCO3 solution and then extracted in CH2Cl2 (3 x 25 mL). The combined organics were 
dried (MgSO4) and concentrated in vacuo to yield SI-2 as a yellow oil. (0.165 g, 91%); Rf 
0.25 (EtOAc). 
1H NMR (400 MHz, CDCl3) d 1.54 (2H, br s, NH2), 2.85 (1H, dd, J = 13.5, 8.0, Phe-CHH), 
3.07 (1H, dd, J = 13.5, 5.3, Phe-CHH), 3.69-3.74 (4H, m, ester-CH3 / Phe-a-CH), 5.22 (1H, 
dd, J = 10.9, 0.9, alkene-CHH), 5.72 (1H, d, J = 17.6, 0.9, alkene-CHH), 6.68 (1H, dd, J = 
17.6, 10.9, alkene-CH), 7.15 (2H, d, J = 8.2, Ar-H), 7.35 (2H, d, J = 8.2, Ar-H). 
13C NMR (100 MHz, CDCl3) d 40.6 (Phe-CH2), 51.9 (ester-CH3), 55.6 (Phe-a-CH), 113.5 
(alkene-CH2), 126.3 (Ar C), 129.3 (Ar C), 131.2 (Ar C), 136.1 (4° Ar C), 136.3 (alkene-CH), 
136.7 (4° Ar C), 175.3 (C=O). 
IR Umax /cm-1 (oil) 3377 m (N-H), 3030 w (C-H), 2793 w (C-H), 1735 s (C=O), 1511 s (C=C), 
1172 s (C-O). 
HRMS (ESI) [M+H+] m/z calcd. for C12H16NO2: 206.1181, found: 206.1182 








The unnatural amino ester H-Phe(4-vinyl)-OMe (SI-2) (0.410 g, 2.00 mmol), acetic anhydride 
(0.945 mL, 10.00 mmol) and pyridine (0.805 mL, 10.00 mmol) were dissolved in CH2Cl2 (20 
mL) and stirred at room temperature for 12 h. The volatiles were removed in vacuo before 
the resulting residue was re-dissolved in CH2Cl2 and washed with 1 M HCl (20 mL), distilled 
H2O (20 mL), sat. aqueous NaHCO3 (20 mL) and distilled H2O (20 mL). The organic layer 
was then dried (MgSO4) and concentrated to dryness. Purification of the crude residue by 
flash column chromatography (EtOAc) followed by recrystallisation from CH2Cl2 / hexanes 
yielded SI-3 as a white solid (0.232 g, 47%); m.p. 123-126 °C, Rf 0.45 (EtOAc). 
1H NMR (400 MHz, CDCl3) d 1.97 (3H, s, acetyl-CH3), 3.05 (1H, dd, J = 13.9, 6.0, Phe-
CHH), 3.13 (1H, dd, J = 13.9, 5.8, Phe-CHH), 3.72 (3H, s, ester-CH3), 4.84-4.90 (1H, m, 
Phe-a-CH), 5.23 (1H, dd, J = 10.9, 0.8, alkene-CHH), 5.72 (1H, dd, J = 17.6, 0.8, alkene-
CHH), 6.23 (1H, d, J = 7.8, Phe-NH), 6.67 (1H, dd, J = 17.6, 10.9, alkene-CH), 7.06 (2H, d, J 
= 8.0, Ar-H), 7.33 (2H, d, J = 8.0, Ar-H). 
13C NMR (100 MHz, CDCl3) d 22.9 (acetyl-CH3), 37.4 (Phe-CH2), 52.2 (ester-CH3), 53.0 
(Phe-a-CH), 113.7 (alkene-CH2), 126.2 (Ar-C), 129.3 (Ar-C), 135.4 (4° Ar-C), 136.2 (alkene-
CH) 136.3 (4° Ar-C), 169.6 (acetyl C=O), 172.0 (ester C=O). 
IR Umax /cm-1 (solid) 3327 m (N-H), 3027 w (C-H), 2958 w (C-H), 1743 s (ester C=O), 1649 s 
(amide C=O), 1534 s (C=C), 1217 s (C-O). 








3.3. Effect of solvent on the C-H olefination of Ac-Gly-Trp(Boc)-OMe (1b) 
 
Peptide 1b (0.100 g, 0.238 mmol), Pd(OAc)2 (5 mg, 0.024 mmol, 10 mol%), AgOAc (0.100 g, 
0.599 mmol) and styrene (0.109 mL, 0.952 mmol) were stirred in solvent (3 mL) at the 
temperature and for the time indicated. The reaction mixture was then allowed to cool to 
room temperature, filtered through a plug of Celite, and the filtrate was concentrated to 
dryness. The resulting crude residue was purified by flash column chromatography (EtOAc) 
and recrystallized from CH2Cl2 / hexanes. 
Table S1. Optimisation of reaction solvent on the C-H olefination of 1b. 
entry solvent T / °C time / h yield a / % 
1 t-amylOH 100 48 60 
2 t-amylOH 100 96 61 
3 1,2-DCE 100 48 60 
4 MeCN 100 48 42 
5 1,4-dioxane 100 48 40 
6 THF 100 48 36 
7 HFIP 100 48 0 
8 PhMe 100 48 85 
9 PhMe 100 2 82 b 
10 PhMe 100 2 74 c 
a Isolated yields of di-olefinated peptide 2b;  
b The di-olefinated peptide 2bʹ was also isolated in 1% yield 






















AgOAc (2.5 eq.), air
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100 °C, 2 h
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3.4. Synthesis of modified peptides 2b and 3a-f 
3.4.1. Synthesis of modified peptide 2b 
 
Following the general procedure in section 2.4, the reaction of Ac-Gly-Trp(Boc)-OMe (1b) 
(0.100 g, 0.238 mmol), Pd(OAc)2 (5 mg, 0.024 mmol, 10 mol%), AgOAc (0.100 g, 0.599 
mmol) and styrene (0.109 mL, 0.952 mmol) gave a crude product that was a mixture of the 
mono-olefinated peptide 2b and the di-olefinated peptide 2b′ in a ratio of 20:1, as judged by 
1H NMR spectroscopy. Purification by flash column chromatography (EtOAc) followed by 
recrystallisation from CH2Cl2 / hexanes gave 2b as an off-white solid (0.101 g, 82); m.p. 116-
118 °C, Rf 0.26 (EtOAc) and 2b′ as an off-white solid (0.002 g, 1%); m.p. 98-99 °C, Rf 0.42 
(EtOAc). 
Data for 2b: 
1H NMR (400 MHz, CDCl3) δ 1.64 (9H, s, Boc-(CH3)3), 1.92 (3H, s, acetyl-CH3), 3.38 (1H, 
dd, J = 14.5, J = 6.6, Trp-CHH), 3.47 (1H, dd, J = 14.5, J = 6.6, Trp-CHH), 3.55 (3H, s, ester-
CH3), 3.74 (1H, dd, J = 16.7, J = 5.0, Gly-CHH), 3.84 (1H, dd, J = 16.7, J = 5.0, Gly-CH2), 
4.89 (1H, dt, J = 7.6, J = 6.6, Trp-α-CH), 5.89 (1H, br t, J = 5.0, Gly-NH), 6.41 (1H, br d, J = 
7.6, Trp-NH), 6.78 (1H, d, J = 16.6, alkene-CH), 7.27-7.34 (4H, m, alkene-CH / Ar-H), 7.39 
(2H, t, J = 7.6, Ar-H), 7.51-7.56 (3H, m, Ar-H), 8.13 (1H, d, J = 8.1, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.9 (acetyl-CH3), 27.3 (Trp-CH2), 28.3 (Boc-(CH3)3), 42.9 
(Gly-CH2), 52.6 (ester-CH3), 52.6 (Trp-α-CH), 84.2 (Boc-C), 114.3 (Ar-C), 115.6 (Ar-C), 
118.5 (Ar-C), 119.9 (alkene-CH), 122.9 (Ar-C), 124.8 (Ar-C), 126.6 (Ar-C), 128.1 (Ar-C), 
128.8 (Ar-C), 129.9 (Ar-C), 132.5 (alkene-CH), 135.8 (Ar-C), 136.2 (Ar-C), 136.7 (Ar-C), 
150.4 (C=O), 168.3 (C=O), 170.3 (C=O), 171.8 (C=O). 
IR Umax /cm-1 (solid) 3281 m (N-H), 2955 w (C-H), 1726 s (ester C=O), 1647 m (amide C=O), 
1523 m (C=C), 1455 m (C-H), 1205 s (C-O).  
HRMS (ESI) [M+H+] m/z calcd. for C29H34N3O6: 520.2442, found: 520.2436. 
ICP analysis of modified peptide 2b indicated more than 99.9% removal of Pd and Ag from 
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Data for 2b′: 
1H NMR (400 MHz, CDCl3) δ 1.60 (9H, s, Boc-(CH3)3), 1.84 (3H, s, acetyl-CH3), 3.43-3.46 
(1H, m, Trp-CHH), 3.50 (3H, s, ester-CH3), 3.63-3.68 (3H, m, Gly-CH2 / Trp-CHH), 4.78-4.84 
(1H, m, Trp-α-CH), 5.92 (1H, br t, J = 4.6, Gly-NH), 6.26 (1H, br d, J = 7.7, Trp-NH), 6.67 
(1H, d, J = 16.6, alkene-CH), 7.04 (1H, d, J = 16.6, alkene-CH), 7.21-7.34 (5H, m, alkene-
CH / Ar-H), 7.35-7.44 (5H, m, Ar-H), 7.53 (2H, d, J = 7.4, Ar-H), 7.57 (2H, d, J = 7.4, Ar-H), 
7.84 (1H, d, J = 16.2, alkene-CH), 8.15 (1H, d, J = 8.1, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.7 (acetyl-CH3), 28.3 (Boc-(CH3)3), 28.5 (Trp-CH2),  42.7 
(Gly-CH2), 52.4 (ester-CH3), 53.1 (Trp-α-CH), 84.2 (Boc-C), 114.7 (Ar-C),114.9 (Ar-C), 119.6 
(Ar-C), 121.8 (Ar-C), 124.8 (Ar-C), 126.6 (Ar-C), 126.6 (Ar-C), 126.8 (Ar-C), 127.8 (Ar-C), 
128.2 (Ar-C), 128.6 (Ar-C), 128.8 (Ar-C), 131.4 (Ar-C), 132.3 (Ar-C), 133.7 (Ar-C), 136.4 (Ar-
C), 136.9 (Ar-C), 137.1 (Ar-C), 137.2 (Ar-C), 150.1 (C=O), 168.4 (C=O), 170.1 (C=O), 171.6 
(C=O).  
IR Umax /cm-1 (solid) 3226 m (N-H), 2978 w (C-H), 1720 s (ester C=O), 1638 m (amide C=O), 
1424 m (C-H), 1250 s (C-O).  
HRMS (ESI) [M+H+] m/z calcd. for C37H40N3O6: 622.2912, found: 622.2910. 
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3.4.2. Synthesis of modified peptide 3a 
 
Modified peptide 3a was prepared from Ac-Gly-Trp(Boc)-OMe (1b) (0.100 g, 0.238 mmol) 
and 4-methylstyrene (0.125 mL, 0.952 mmol), using the general procedure in section 2.4. 
As judged by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-
olefinated peptide 3a and a di-olefinated peptide in a ratio of 24:1. Purification by flash 
column chromatography (EtOAc) gave 3a as a yellow oil (0.099 g, 78%); Rf 0.25 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.63 (9H, s, Boc-(CH3)3), 1.91 (3H, s, acetyl-CH3), 2.37 (3H, s, 
Ar-CH3), 3.37 (1H, dd, J = 14.4, J = 6.4, Trp-CHH), 3.46 (1H, dd, J = 14.4, J = 6.4, Trp-
CHH), 3.55 (ester-CH3), 3.72 (1H, dd, J = 16.8, J = 5.0, Gly-CHH), 3.83 (1H, dd, J = 16.8, J 
= 5.0, Gly-CHH), 4.88 (1H, dt, J = 7.6, J = 6.4, Trp-α-CH), 5.86 (1H, m, Gly-NH), 6.38 (1H, br 
d, J = 7.6, Trp-NH), 6.73 (1H, d, J = 16.7, alkene-CH), 7.18-7.24 (2H, m, alkene-CH / Ar-H), 
7.27-7.32 (2H, m, Ar-H), 7.38 (1H, d, J = 4.6, Ar-H), 7.44 (2H, d, J = 8.0, Ar-H), 7.51 (1H, br 
d, J = 7.0, Ar-H), 8.13 (1H, d, J = 8.0, Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 21.3 (Ar-CH3), 22.8 (acetyl-CH3), 27.2 (Trp-CH2), 28.2 
(Boc-(CH3)3), 42.9 (Gly-CH2), 52.5 (ester-CH3), 52.6 (Trp-α-CH), 84.0 (Boc-C), 114.2 (Ar-C), 
115.5 (Ar-C), 118.4 (Ar-C), 118.8 (alkene-C), 122.8 (Ar-C), 124.7 (Ar-C), 126.4 (Ar-C), 127.0 
(Ar-C), 128.5 (Ar-C), 129.4 (Ar-C), 129.9 (Ar-C), 132.4 (alkene-C), 133.9 (Ar-C), 135.8 (Ar-
C), 136.3 (Ar-C), 138.0 (Ar-C), 150.4 (C=O), 168.4 (C=O), 170.3 (C=O), 171.8 (C=O).  
IR Umax /cm-1 (oil) 3286 m (N-H), 3053 w (C-H), 2978 w (C-H), 1728 s (ester C=O), 1648 m 
(amide C=O), 1235 s (C-O).  












3.4.3. Synthesis of modified peptide 3b 
 
Modified peptide 3b was prepared from Ac-Gly-Trp(Boc)-OMe (1b) (0.100 g, 0.238 mmol) 
and 4-chlorostyrene (0.114 mL, 0.952 mmol), using the general procedure in section 2.4. As 
judged by 1H NMR spectroscopy, the crude residue contained only the mono-olefinated 
peptide 3b. Purification by flash column chromatography (EtOAc) gave 3b as a yellow oil 
(0.113 g, 87%); Rf 0.27 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.63 (9H, s, Boc-(CH3)3), 1.92 (3H, s, acetyl-CH3), 3.33 (1H, 
dd, J = 14.4, J = 6.6, Trp-CHH), 3.41 (1H, dd, J = 14.4, J = 6.6, Trp-CHH), 3.53 (3H, s, ester-
CH3), 3.72 (1H, dd, J = 16.7, J = 5.0, Gly-CHH), 3.83 (1H, dd, J = 16.7, J = 5.0, Gly-CHH), 
4.87 (1H, dt, J = 7.4, J = 6.6, Trp-α-CH), 6.01 (1H, br t, J = 5.0, Gly-NH), 6.73 (1H, d, J = 
16.9, alkene-CH), 7.22-7.24 (6H, m, alkene-CH / Ar-H), 7.46-7.52 (3H, m, Ar-H), 8.10 (1H, d, 
J = 8.2, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.8 (acetyl-CH3), 27.4 (Trp-CH2), 28.2 (Boc-(CH3)3), 43.0 
(Gly-CH2), 52.6 (ester-CH3), 52.6 (Trp-α-CH), 84.2 (Boc-C), 114.6 (Ar-C), 115.6 (Ar-C), 
118.5 (Ar-C), 122.9 (Ar-C), 124.9 (Ar-C), 127.0 (Ar-C), 127.7 (Ar-C), 128.5 (Ar-C), 128.9 (Ar-
C), 129.9 (Ar-C), 130.9 (Ar-C), 133.6 (Ar-C), 135.3 (Ar-C), 135.8 (Ar-C), 150.3 (C=O), 168.4 
(C=O), 170.4 (C=O), 171.8 (C=O).  
IR Umax /cm-1 (oil) 3281 m (N-H), 2950 w (C-H), 1728 s (ester C=O), 1648 m (amide C=O), 
1455 m (C-H).  












3.4.4. Synthesis of modified peptide 3c 
 
Modified peptide 3c was prepared from Ac-Gly-Trp(Boc)-OMe (1b) (0.100 g, 0.238 mmol) 
and 4-methoxystyrene (0.127 mL, 0.952 mmol), using the general procedure in section 2.4. 
As judged by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-
olefinated peptide 3c and a di-olefinated peptide in a ratio of 14:1. Purification by flash 
column chromatography (EtOAc) followed by recrystallisation from CH2Cl2 / hexanes gave 
3c as yellow solid (0.077 g, 59%); m.p. 150-152 °C, Rf 0.18 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.62 (9H, s, Boc-(CH3)3), 1.90 (3H, s, acetyl-CH3), 3.35 (1H, 
dd, J = 14.2, J = 6.6, Trp-CHH), 3.44 (1H, dd, J = 14.2, J = 6.6, Trp-CHH), 3.54 (3H, s, ester-
CH3), 3.71 (1H, dd, J = 16.9, J = 5.0, Gly-CHH), 3.80-3.85 (4H, m, Ph-OCH3 / Gly-CHH), 
4.87 (1H, dt, J = 7.4, J = 6.6, Trp-α-CH), 5.92 (1H, br t, J = 5.0, Gly-NH), 6.44 (1H, d, J = 7.4, 
Trp-NH), 6.70 (1H, d, J = 16.4, alkene-CH), 6.91 (2H, d, J = 8.9, Ar-H), 7.15 (1H, d, J = 16.4, 
alkene-CH), 7.21-7.24 (1H, m, Trp-Ar-H), 7.26-7.30 (1H, m, Trp-Ar-H), 7.36 (1H, d, J = 4.6, 
Ar-H), 7.46-7.50 (3H, m, Ar-H), 8.11 (1H, d, J = 8.2, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.8 (acety-CH3), 27.2 (Trp-CH2), 28.3 (Boc-(CH3)3), 42.9 
(Gly-CH2), 52.6 (ester-CH3), 55.3 (Trp-α-CH), 84.0 (Boc-C), 113.8 (OMe), 114.2 (Ar-C), 
115.6 (Ar-C), 117.7 (Ar-C), 118.4 (Ar-C), 122.8 (Ar-C), 124.6 (Ar-C), 127.0 (Ar-C), 127.8 (Ar-
C), 128.5 (Ar-C), 129.5 (Ar-C), 130.0 (Ar-C), 132.1 (Ar-C), 135.8 (Ar-C), 136.5 (Ar-C), 150.4 
(C=O), 168.3 (C=O), 170.3 (C=O), 171.8 (C=O).   
IR Umax /cm-1 (solid) 3296 m (N-H), 3051 w (C-H), 2963 w (C-H), 1727 s (ester C=O), 1658 m 
(amide C=O), 1510 m (C=C), 1260 s (C-O).  












3.4.5. Synthesis of modified peptide 3d 
 
Modified peptide 3d was prepared from Ac-Gly-Trp(Boc)-OMe (1b) (0.100 g, 0.238 mmol) 
and 4-(trifluoromethyl)styrene (0.141 mL, 0.952 mmol), using the general procedure in 
section 2.4. As judged by 1H NMR spectroscopy, the crude residue contained a mixture of 
the mono-olefinated peptide 3d and a di-olefinated peptide in a ratio of 13:1. Purification by 
flash column chromatography (EtOAc) followed by recrystallisation from CH2Cl2 / hexanes 
gave 3d as an off-white solid (0.099 g, 71%); m.p. 169-172 °C, Rf 0.36 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.63 (9H, s, Boc-(CH3)3), 1.91 (3H, s, acetyl-CH3), 3.33 (1H, 
dd, J = 14.6, J = 6.4, Trp-CHH), 3.41 (1H, dd, J = 14.6, J = 6.4, Trp-CHH), 3.53 (3H, s, ester-
CH3), 3.74 (1H, dd, J = 16.9, J = 5.0, Gly-CHH), 3.85 (1H, dd, J = 16.9, J = 5.0, Gly-CHH), 
4.89 (1H, dt, J = 7.8, J = 6.6, Trp-α-CH), 6.10 (1H, br t, J = 5.0, Gly-NH), 6.72 (1H, d, J = 7.8, 
Trp-NH), 6.81 (1H, d, J = 16.6, alkene-CH), 7.22-7.26 (1H, m, Ar-H), 7.29-7.35 (2H, m, Ar-
H), 7.45 (1H, d, J = 16.6, alkene-CH), 7.52 (1H, d, J = 7.3, Ar-H), 7.63 (4H, dt, J = 8.2, J = 
7.3, Ar-H), 8.11 (1H, d, J = 8.2, Ar-H).   
13C{1H} NMR (100 MHz, CDCl3) δ 22.8 (acetyl-CH3), 27.6 (Trp-CH2), 28.2 (Boc-(CH3)3), 43.0 
(Gly-CH2), 52.6 (ester-CH3), 52.6 (Trp-α-CH), 84.3 (Boc-C), 115.1 (Ar-C), 155.6 (Ar-C), 
118.6 (Ar-C), 122.5 (Ar-C), 123.0 (Ar-C), 125.1 (Ar-C), 125.6 (Ar-C), 126.6 (Ar-C), 127.6 (Ar-
C), 128.5 (Ar-C), 129.8 (Ar-C), 130.5 (Ar-C), 135.4 (Ar-C), 135.8 (Ar-C), 140.3 (Ar-C), 150.3 
(C=O), 168.4 (C=O), 170.5 (C=O), 171.9 (C=O).  
IR Umax /cm-1 (solid) 3282 m (N-H), 3070 w (C-H), 2980 w (C-H), 1728 s (ester C=O), 1647 m 
(amide C=O), 1541 m (C=C), 1237 s (C-O).  












3.4.6. Synthesis of modified peptide 3e 
 
Modified peptide 3e was prepared from Ac-Gly-Trp(Boc)-OMe (1b) (0.100 g, 0.238 mmol) 
and 4-cyanostyrene (0.123 mL, 0.952 mmol), using the general procedure in section 2.4. As 
judged by 1H NMR spectroscopy, the crude residue contained only the mono-olefinated 
peptide 3e. Purification by flash column chromatography (EtOAc) followed by 
recrystallisation from CH2Cl2 / hexanes gave 3e as a yellow solid (0.105 g, 81%); m.p. 144-
147 °C, Rf 0.18 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.64 (9H, s, Boc-(CH3)3), 1.95 (3H, s, acetyl-CH3), 3.31-3.41 
(2H, m, Trp-CH2), 3.52 (3H, s, ester-CH3), 3.76 (1H, dd, J = 16.6, J = 5.0, Gly-NH), 3.86 (1H, 
dd, J = 16.6, J = 5.0, Gly-CHH), 4.88 (1H, app q, J = 8.2, Trp-α-CH), 6.04 (1H, br t, J = 5.0, 
Gly-NH), 6.65 (1H, d, J = 8.2, Trp-NH), 6.83 (1H, d, J = 16.4, alkene-CH), 7.23-7.27 (1H, m, 
Ar-H), 7.30-7.36 (2H, m, Ar-H), 7.49-7.53 (2H, m, alkene-CH / Ar-H), 7.65 (4H, s, Ar-H), 8.09 
(1H, d, J = 8.2, Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 22.9 (acetyl-CH3), 27.8 (Trp-CH2), 28.2 (Boc-(CH3)3), 43.1 
(Gly-CH2), 52.6 (ester-CH3), 52.6 (Trp-α-CH), 84.5 (Boc-C), 110.9 (Ar-C), 115.5 (Ar-C), 
115.7 (Ar-C), 118.7 (Ar-C), 119.0 (Ar-C), 123.1 (Ar-C), 123.7 (Ar-C), 125.33 (Ar-C), 127.0 
(Ar-C), 129.8 (Ar-C), 130.0 (Ar-C), 132.5 (Ar-C), 135.8 (Ar-C), 141.4 (Ar-C), 150.3 (C=O), 
168.4 (C=O), 170.5 (C=O), 171.9 (C=O).    
IR Umax /cm-1 (solid) 3283 m (N-H), 3050 w (C-H), 2979 w (C-H), 2225 s (C≡N), 1728 s (ester 
C=O), 1649 m (amide C=O), 1239 s (C-O).  












3.4.7. Synthesis of modified peptide 3f 
 
 
The peptide Ac-Gly-Trp(Boc)-OMe (1b) (0.030 g, 0.071 mmol), Pd(OAc)2 (1 mg, 0.003 
mmol, 10 mol%), AgOAc (0.030 g, 0.180 mmol) and Ac-Phe(4-vinyl)-OMe (SI-3) (0.071 g, 
0.287 mmol) were stirred in toluene (3 mL) at 100 °C for 2 h. The reaction mixture was then 
allowed to cool to room temperature, filtered through a plug of Celite, and concentrated to 
dryness. As judged by 1H NMR spectroscopy, the crude residue contained only the mono-
olefinated peptide 3f. Purification by flash column chromatography (EtOAc), followed by 
recrystallisation from CH2Cl2 / hexanes, gave 3f as a yellow solid (0.032 g, 64%); m.p. 239-
242 °C, Rf 0.10 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.64 (9H, s, Boc-CH3), 1.92 (3H, s, acetyl-CH3), 2.02 (3H, s, 
acetyl-CH3), 3.10 (1H, dd, J = 14.0, 5.6, Phe-CHH), 3.17 (1H, dd, J = 14.0, 5.5, Phe-CHH), 
3.35 (1H, dd, J = 14.5, 6.5, Trp-CHH), 3.42 (1H, dd, J = 14.5, 6.6, Trp-CHH), 3.54 (3H, s, 
ester-CH3), 3.67-3.79 (5H, m, ester-CH3 / Gly-CH2), 4.87-4.97 (2H, m, Phe-α-CH / Trp-α-
CH), 6.23 (1H, t, J = 4.9, Gly-NH), 6.30 (1H, d, J = 8.0, Phe-NH), 6.68-6.75 (2H, m, alkene-
CH / Trp-NH), 7.09 (2H, d, J = 8.1, Ar-H), 7.22-7.35 (3H, m, Ar-H / alkene-CH), 7.45 (2H, d, 
J = 8.1, Ar-H), 7.53 (1H, d, J = 7.7, Ar-H), 8.10 (1H, d, J = 8.0, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.8 (acetyl-CH3), 23.1 (acetyl-CH3), 27.4 (Trp-CH2), 28.2 
(Boc-(CH3)3), 37.6 (Phe-CH2), 42.9 (Gly-CH2), 52.4 (ester-CH3), 52.5 (ester-CH3), 52.5 (Trp-
α-CH), 53.0 (Phe-α-CH), 84.2 (Boc-C), 114.4 (Ar-C), 115.6 (Ar-C), 118.5 (Ar-C), 119.9 
(alkene-C), 122.9 (Ar-C), 124.8 (Ar-C), 126.7 (Ar-C), 129.7 (Ar-C), 129.8 (Ar-C), 131.9 
(alkene-C), 135.6 (Ar-C), 135.7 (Ar-C), 135.8 (Ar-C), 136.1 (Ar-C) 150.4 (Boc C=O), 160.5 
(C=O), 169.9 (C=O), 170.5 (C=O), 172.0 (C=O), 172.0 (C=O). 
IR Umax /cm-1 (solid) 3291 w (N-H), 3055 w (C-H), 2952 w (C-H), 1728 s (ester C=O), 1653 s 
(amide C=O), 1523 s (C=C), 1210 s (C-O). 























Pd(OAc)2 (10 mol %)
AgOAc (2.5 eq), air








3.5. Detailed synthetic method at >1 mmol scale 
 
The peptide Ac-Gly-Trp(Boc)-OMe (1b) (1.14 mmol), Pd(OAc)2 (24 mg, 0.114 mmol, 10 
mol%), AgOAc (0.479 g, 2.85 mmol) and styrene (0.52 mL, 4.56 mmol) were stirred in 
toluene (14 mL) at 100 °C for 2 h. The reaction mixture was then allowed to cool to room 
temperature, filtered through a plug of Celite, and concentrated to dryness. Purification by 
flash column chromatography (EtOAc) followed by recrystallisation from CH2Cl2 / hexanes 





















Pd(OAc)2 (10 mol %)
AgOAc (2.5 eq), air
PhMe (0.08 M)
100 °C, 2 h
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3.6. Synthesis of Trp containing peptides 4a-j 
3.6.1. Synthesis of Ac-Ala-Trp(Boc)-OMe (4a) 
Ac-Ala-Trp-OMe (SI-4) 
 
The peptide Ac-Ala-Trp-OMe (SI-4) was synthesised from L-tryptophan methyl ester 
hydrochloride (0.637 g, 2.50 mmol) and N-acetyl-L-alanine (0.131 g, 1.00 mmol), using the 
procedure in section 2.1. The crude compound was recrystallised from CH2Cl2 / hexanes to 
afford SI-4 as an off-white solid (0.315 g, 95%); m.p. 77-79 °C. 
1H NMR (400 MHz, CDCl3) δ 1.30 (3H, d, J = 6.9, Ala-CH3), 1.86 (3H, s, acetyl-CH3), 3.27-
3.36 (2H, m, Trp-CH2), 4.48 (1H, dq, J = 7.3, J = 6.9, Ala-α-CH), 4.88 (1H, dt, J = 7.8, J = 
5.5, Trp-α-CH), 5.57 (1H, br d, J = 7.3, Ala-NH), 6.49 (1H, br d, J = 7.8, Trp-NH), 7.03 (1H, 
d, Trp-Ar-H), 7.09-7.19 (1H, m, Trp-Ar-H), 7.16-7.20 (1H, m, Trp-Ar-H), 7.33-7.36 (1H, m, 
Trp-Ar-H), 7.50-7.51 (1H, m, Trp-Ar-H), 8.18 (1H, br s, Trp-Ar-NH). 
13C{1H} NMR (100 MHz, CDCl3) δ 18.3 (Ala-CH3), 23.0 (acetyl-CH3), 27.3 (Trp-CH2), 48.7 
(Ala-α-CH), 52.5 (ester-CH3), 52.9 (Trp-α-CH), 109.6 (Ar-C), 111.3 (Ar-C), 118.5 (Ar-C), 
119.7 (Ar-C), 122.3 (Ar-C), 123.1 (Ar-C), 127.5 (Ar-C), 136.0 (Ar-C), 169.8 (C=O), 171.8 
(C=O), 172.0 (C=O).  
IR Umax /cm-1 (solid) 3276 m (N-H), 3060 w (C-H), 2976 w (C-H), 1723 s (ester C=O), 1631 m 
(amide C=O), 1550 m (C=C), 1405 m (C-H), 1256 s (C-O).  














Peptide 4a was synthesised from Ac-Ala-Trp-OMe (SI-4) (0.249 g, 0.75 mmol) using the 
procedure in section 2.3. Purification by flash column chromatography (EtOAc) followed by 
recrystallisation from CH2Cl2 / hexanes gave 4a as an off-white solid (0.291 g, 90%); m.p. 
83-84 °C, Rf 0.19 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.33 (3H, d, J = 6.9, Ala-CH3), 1.66 (9H, s, Boc-(CH)3)3), 1.90 
(3H, s, acetyl-CH3), 3.20 (1H, dd, J = 14.6, J = 5.5, Trp-CHH), 3.30 (1H, dd, J = 14.6, J = 
5.5, Trp-CHH), 3.71 (3H, s, ester-CH3), 4.39-4.47 (1H, m, Ala-α-CH), 4.85-4.90 (1H, m, Trp-
α-CH), 5.91 (1H, br d, J = 7.3, Ala-NH), 6.59 (1H, br d, J = 7.3, Trp-NH), 7.22 (1H, t, J = 7.3, 
Trp-Ar-H), 7.30 (1H, t, J = 7.3, Trp-Ar-H), 7.39 (1H, s, Trp-Ar-H), 7.47 (1H, d, J = 7.3, Trp-Ar-
H), 8.08-8.10 (1H, m, Trp-Ar-H),  
13C{1H} NMR (100 MHz, CDCl3) δ 18.1 (Ala-CH3), 22.8 (acetyl-CH3), 27.2 (Trp-CH2), 28.1 
(Boc(CH3)3), 48.6 (Ala-α-CH), 52.4 (ester-CH3), 52.6 (Trp-α-CH), 83.7 (Boc-C), 114.8 (Ar-C), 
115.2 (Ar-C), 118.7 (Ar-C),122.5 (Ar-C), 124.1 (Ar-C), 124.4 (Ar-C), 130.3 (Ar-C), 135.1 (Ar-
C), 149.5 (C=O), 170.0 (C=O), 171.7 (C=O), 172.3 (C=O). 
IR Umax /cm-1 (solid) 3286 m (N-H), 2933 w (C-H), 1728 s (ester C=O), 1648 m (amide C=O), 
1452 m (C-H), 1213 s (C-O).  













3.6.2. Synthesis of Ac-Leu-Trp(Boc)-OMe (4b) 
Ac-Leu-Trp-OMe (SI-5) 
 
The peptide Ac-Leu-Trp-OMe (SI-5) was synthesised from L-tryptophan methyl ester 
hydrochloride (0.637 g, 2.50 mmol) and N-acetyl-L-leucine (0.173 g, 1.00 mmol), using the 
procedure in section 2.1. The crude compound was recrystallised from CH2Cl2 / hexanes to 
afford SI-5 as a white solid (0.261 g, 78%); m.p. 79-81 °C. 
1H NMR (400 MHz, CDCl3) δ 0.84-0.86 (6H, m, Leu-CH3 (x2)), 1.48-1.64 (3H, m, (Leu-
CH/Leu-CH2), 1.80 (3H, s, acetyl-CH3), 3.25-3.37 (2H, m, Trp-CH2), 3.64 (3H, s, ester-CH3), 
4.56 (1H, dt, J = 8.0, J = 5.6, Leu-α-CH), 4.86 (1H, dt, J = 7.7, J = 5.4, Trp-α-CH), 6.65 (1H, 
br d, J = 8.0, Leu-NH), 6.99 (1H, d, J = 2.1, Trp-Ar-H), 7.03-7.14 (2H, m, Trp-Ar-H / Trp-NH), 
7.10-7.16 (1H, br d, J = 7.7, Trp-Ar-H), 7.26-7.28 (1H, m, Trp-Ar-H), 7.49 (1H, d, J = 7.7, 
Trp-Ar-H), 8.73 (1H, s, Trp-Ar-NH). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.2 (Leu-CH3 x2), 22.9 (Leu-CH2), 23.1 (acetyl-CH3), 
24.8 (Leu-CH(CH3)2), 27.5 (Trp-CH2), 41.3 (Leu-CH2), 51.7 (Leu-α-CH), 52.6 (ester-CH3), 
52.9 (Trp-α-CH), 109.5 (Ar-C), 111.4 (Ar-C), 118.6 (Ar-C), 119.7 (Ar-C), 122.2 (Ar-C), 123.5 
(Ar-C), 127.6 (Ar-C), 136.1 (Ar-C), 170.2 (C=O), 172.0 (C=O), 172.1 (C=O).  
IR Umax /cm-1 (solid) 3226 m (N-H), 3058 w (C-H), 2954 w (C-H), 1733 s (ester C=O), 1638 m 
(amide C=O), 1541 m (C=C), 1452 m (C-H), 1254 s (C-O).  












Peptide 4b was synthesised from Ac-Leu-Trp-OMe (SI-5) (0.280 g, 0.75 mmol) using the 
procedure in section 2.3. Purification by flash column chromatography (75% EtOAc/pet. 
ether) followed by recrystallisation from CH2Cl2 / hexanes gave 4b as a white solid (0.337 g, 
95%); m.p. 84-86 °C, Rf 0.20 (75% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 0.86-0.91 (6H, m, Leu-CH3 (x2)), 1.46-1.50 (1H, m, Leu-CH), 
1.59-1.63 (2H, m, Leu-CH2), 1.66 (9H, s, Boc-(CH3)3), 1.91 (3H, s, acetyl-CH3), 3.19 (1H, dd, 
J = 14.7, J = 5.8, Trp-CHH),  3.26 (1H, dd, J = 14.7, J = 5.8, Trp-CHH), 3.68 (3H, s, ester-
CH3), 4.49 (1H, dt, J = 8.4, J = 5.4, Leu-α-CH), 4.83-4.88 (1H, m, Trp-α-CH), 6.24 (1H, br d, 
J = 8.4, Leu-NH), 6.93 (1H, br d, J = 7.3, Trp-NH), 7.20-7.24 (1H, m, Trp-Ar-H), 7.28-7.32 
(1H, m, Trp-Ar-H), 7.46 (1H, s, Trp-Ar-H), 7.49 (1H, d, J = 7.7, Trp-Ar-H), 8.06-8.10 (1H, m, 
Trp-Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.0 (Leu-CH3), 22.9 (Leu-CH3), 23.0 (acetyl-CH3), 24.7 
(Leu-CH), 27.3 (Trp-CH2), 28.2 (Boc-(CH3)3), 41.0 (Leu-CH2), 51.6 (Leu-α-CH), 52.5 (ester-
CH3), 52.6 (Trp-α-CH), 83.8 (Boc-C), 114.8 (Ar-C), 115.3 (Ar-C), 118.8 (Ar-C), 122.6 (Ar-C), 
124.3 (Ar-C), 124.5 (Ar-C), 130.4 (Ar-C), 135.2 (Ar-C), 149.6 (C=O), 170.2 (C=O), 171.8 
(C=O), 172.1 (C=O). 
IR Umax /cm-1 (solid) 3284 m (N-H), 2932 w (C-H), 1731 s (ester C=O), 1647 m (amide C=O), 
1526 m (C=C), 1452 m (C-H), 1254 s (C-O).  











3.6.3. Synthesis of Ac-Met-Trp(Boc)-OMe (4c) 
Ac-Met-Trp-OMe (SI-6) 
 
The peptide Ac-Met-Trp-OMe (SI-6) was synthesised from L-tryptophan methyl ester 
hydrochloride (0.637 g, 2.50 mmol) and N-acetyl-L-methionine (0.191 g, 1.00 mmol), using 
the procedure in section 2.1. The crude compound was recrystallised from CH2Cl2 / 
hexanes to afford SI-6 as a white solid (0.376 g, 96%); m.p. 70-72 °C. 
1H NMR (400 MHz, CDCl3) δ 1.82-1.90 (4H, m, acetyl-CH3 / Met-CHH), 1.96-2.02 (4H, m, 
Met-CH3 / Met-CHH), 2.48 (2H, br t, J = 7.4, Met-CH2), 3.26 (2H, br d, J = 5.6, Trp-CH2), 
3.65 (3H, s, ester-CH3), 4.65-4.71 (1H, m, Met-α-CH), 4.82-4.87 (1H, m, Trp-α-CH), 6.94 
(1H, s, Trp-Ar-H), 7.01-7.08 (2H, m, Trp-Ar-H / Met-NH), 7.12 (1H, t, J = 7.6, Trp-Ar-H), 7.26 
(1H, br d, J = 7.6, Trp-Ar-H), 7.32 (1H, br d, J = 7.6, Trp-NH), 7.49 (1H, br d, J = 7.6, Trp-Ar-
H), 8.82 (1H, m, Trp-Ar-NH).      
13C{1H}  NMR (100 MHz, CDCl3) δ 14.9 (Met-CH3), 23.1 (acetyl-CH3), 27.3 (Trp-CH2), 29.9 
(Met-CH2), 31.5 (Met-CH2), 51.9 (Met-α-CH), 52.5 (ester-CH3), 52.8 (Trp-α-CH), 109.5 (Ar-
C), 111.4 (Ar-C), 118.4 (Ar-C), 119.7 (Ar-C), 122.3 (Ar-C), 123.1 (Ar-C), 127.4 (Ar-C), 136.1 
(Ar-C), 169.9 (C=O), 170.8 (C=O), 171.9 (C=O). 
IR Umax /cm-1 (solid) 3275 m (N-H), 3058 w (C-H), 2976 w (C-H), 1731 s (ester C=O), 1640 m 
(amide C=O), 1451 m (C-H), 1254 s (C-O).  














Peptide 4c was synthesised from Ac-Met-Trp-OMe (SI-6) (0.294 g, 0.75 mmol) using the 
procedure in section 2.3. Purification by flash column chromatography (75% EtOAc/pet. 
ether) followed by recrystallisation from CH2Cl2 / hexanes gave 4c as a white solid (0.262 g, 
71%); m.p. 80-81 °C, Rf 0.17 (75% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.59 (9H, s, Boc-(CH3)3), 1.84-1.88 (4H, m, acetyl-CH3 / Met-
CHH), 1.94-1.97 (4H, m, Met-CHH / Met-CH3), 2.42-2.52 (2H, m, Met-CH2), 3.13 (1H, dd, J = 
14.8, J = 6.2, Trp-CHH), 3.18 (1H, dd, J = 14.8, J = 6.2, Trp-CHH), 3.62 (3H, s, ester-CH3), 
4.54 (1H, app q, J = 7.1, Met-α-CH), 4.78-4.82 (1H, m, Trp-α-CH), 6.42 (1H, br d, J = 7.1, 
Met-NH), 6.98 (1H, br d, J = 7.7, Trp-NH), 7.12-7.16 (1H, m, Trp-Ar-H), 7.20-7.24 (1H, m, 
Trp-Ar-H), 7.36 (1H, br s, Trp-Ar-H), 7.40 (1H, d, J = 7.9, Trp-Ar-H), 8.01 (1H, m, Trp-Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 14.9 (Met-CH3), 22.9 (acetyl-CH3), 27.2 (Trp-CH2), 28.1 
(Boc-(CH3)3), 29.8 (Met-CH2), 31.4 (Met-CH2), 51.8 (Met-α-CH), 52.4 (ester-CH3), 52.5 (Trp-
α-CH), 83.7 (Boc-C), 114.6 (Ar-C), 115.2 (Ar-C), 118.6 (Ar-C),122.5 (Ar-C),124.1 (Ar-C), 
124.5 (Ar-C), 130.1 (Ar-C), 135.2 (Ar-C), 148.4 (C=O), 170.0 (C=O), 171.1 (C=O), 171.5 
(C=O)  
IR Umax /cm-1 (solid) 3287 m (N-H), 3050 w (C-H), 2978 w (C-H), 1739 s (ester C=O), 1636 m 
(amide C=O), 1445 m (C-H), 1220 s (C-O).  













3.6.4. Synthesis of Ac-Phe-Trp(Boc)-OMe (4d) 
Ac-Phe-Trp-OMe (SI-7) 
 
The peptide Ac-Phe-Trp-OMe (SI-7) was synthesised from L-tryptophan methyl ester 
hydrochloride (0.637 g, 2.50 mmol) and N-acetyl-L-phenylalanine (0.207 g, 1.00 mmol), 
using the procedure in section 2.1. The crude compound was recrystallised from CH2Cl2 / 
hexanes to afford SI-7 as an off-white solid (0.363 g, 89%); m.p. 75-76 °C. 
1H NMR (400 MHz, CDCl3) δ 1.70 (3H, s, acetyl-CH3), 2.95 (1H, dd, J = 14.0, J = 6.7, Phe-
CHH), 3.03 (1H, dd, J = 14.0, J = 6.7, Phe-CHH), 3.22 (2H, d, J = 5.5, Trp-CH2), 3.62 (3H, s, 
ester-CH3), 4.76 (1H, app q, J = 7.6, Phe-α-CH), 4.81-4.86 (1H, m, Trp-α-CH), 6.41 (1H, d, J 
= 7.6, Phe-NH), 6.83 (1H, d, J = 7.8, Trp-NH), 6.86 (1H, d, J = 1.8, Ar-H), 7.02 (1H, t, J = 
7.8, Ar-H), 7.09-7.14 (3H, m, Ar-H), 7.19-7.26 (4H, m, Ar-H), 7.37 (1H, d, J = 7.8, Ar-H), 8.54 
(1H, m, Trp-Ar-NH). 
13C{1H} NMR (100 MHz, CDCl3) δ 23.0 (acetyl-CH3), 27.4 (Trp-CH2), 38.1 (Phe-CH2), 52.4 
(ester-CH3), 52.9 (Trp-α-CH), 54.1 (Phe-α-CH), 109.5 (Ar-C), 111.4 (Ar-C), 118.4 (Ar-C), 
119.7 (Ar-C), 122.3 (Ar-C), 123.1 (Ar-C), 127.0 (Ar-C), 127.4 (Ar-C), 128.6 (Ar-C), 129.4 (Ar-
C), 136.0 (Ar-C), 136.4 (Ar-C), 169.9 (C=O), 170.3 (C=O), 171.6 (C=O). 
IR Umax /cm-1 (solid) 3275 m (N-H), 3024 w (C-H), 2989 w (C-H), 1727 s (ester C=O), 1646 m 
(amide C=O), 1550 m (C=C), 1401 m (C-H), 1220 s (C-O).  













Peptide 4d was synthesised from Ac-Phe-Trp-OMe (SI-7) (0.306 g, 0.75 mmol) using the 
procedure in section 2.3. Purification by flash column chromatography (75% EtOAc/pet. 
ether) followed by recrystallisation from CH2Cl2 / hexanes gave 4d as a white solid (0.305 g, 
80%); m.p. 79-81 °C, Rf 0.28 (75% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.59 (9H, s, Boc-(CH3)3), 1.79 (3H, s, acetyl-CH3), 2.93 (1H, 
dd, J = 13.8, J = 7.4, Phe-CHH), 2.97-3.18 (2H, m, Phe-CHH / Trp-CHH), 3.13 (1H, dd, J = 
14.8, J = 5.8, Trp-CHH), 3.59 (3H, s, ester-CH3), 4.57 (1H, app q, J = 7.3, Phe-α-CH), 4.75 
(1H, dt, J = 7.6, J = 5.8, Trp-α-CH), 6.03 (1H, br d, J = 7.6, Trp-NH), 6.31 (1H, br d, J = 7.4, 
Phe-NH), 7.07-7.12 (3H, m, Ar-H), 7.13-7.22 (4H, m, Ar-H), 7.24-7.28 (2H, m, Ar-H), 8.01 
(1H, m Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.9 (acetyl-CH3), 27.3 (Trp-CH2), 28.1 (Boc-(CH3)3), 38.0 
(Phe-CH2), 52.4 (ester-CH3), 52.6 (Trp-α-CH), 54.2 (Phe-α-CH), 83.7 (Boc-C), 114.5 (Ar-C), 
115.3 (Ar-C), 118.6 (Ar-C), 122.5 (Ar-C), 124.2 (Ar-C), 124.5 (Ar-C), 126.9 (Ar-C), 128.5 (Ar-
C), 129.2 (Ar-C), 130.2 (Ar-C), 135.2 (Ar-C), 136.3 (Ar-C), 149.5 (C=O), 169.9 (C=O), 170.6 
(C=O), 171.3 (C=O).   
IR Umax /cm-1 (solid) 3278 m (N-H), 3033 w (C-H), 2934 w (C-H), 1736 s (ester C=O), 1642 m 
(amide C=O), 1441 m (C-H), 1235 s (C-O).  











3.6.5. Synthesis of Ac-Trp(Boc)-Leu-OMe (4e) 
Ac-Trp-Leu-OMe (SI-8) 
 
The peptide Ac-Trp-Leu-OMe (SI-8) was synthesised from L-leucine methyl ester 
hydrochloride (0.454 g, 2.50 mmol) and N-acetyl-L-tryptophan (0.246 g, 1.00 mmol), using 
the procedure in section 2.1. The crude compound was recrystallised from CH2Cl2 / 
hexanes to afford SI-8 as a yellow solid (0.295 g, 79%); m.p. 74-76 °C. 
1H NMR (400 MHz, CDCl3) δ 0.83-0.89 (6H, m, Leu-CH3 (x2)), 1.09-1.17 (1H, m, Leu-CH), 
1.46-1.53 (2H, m, Leu-CH2), 2.00 (3H, s, acetyl-CH3), 3.14 (1H, dd, J = 14.5, J = 8.3, Trp-
CHH), 3.29-3.35 (1H, m, Trp-CHH), 3.66 (3H, s, ester-CH3), 4.48 (1H, dt, J = 8.3, J = 5.2, 
Trp-α-CH), 4.73-4.78 (1H, m, Leu-NH), 6.04-6.06 (1H, m, Trp-NH), 6.34-6.35 (1H, m, Leu-
NH), 7.12-7.16 (2H, m, Trp-Ar-H), 7.21 (1H, t, J = 7.6, Trp-Ar-H), 7.37 (1H, d, J = 7.6, Trp-Ar-
H), 7.75 (1H, d, J = 7.6, Trp-Ar-H), 8.17 (1H, m, Trp-Ar-NH). 
13C{1H} NMR (100 MHz, CDCl3) δ 21.8 (Leu-CH3), 22.6 (Leu-CH3), 23.3 (acetyl-CH3), 24.6 
(Leu-CH), 28.5 (Trp-CH2), 41.4 (Leu-CH2), 50.9 (Leu-α-CH), 52.2 (ester-CH3), 53.7 (Trp-α-
CH), 110.6 (Ar-C), 111.1 (Ar-C), 118.9 (Ar-C), 119.8 (Ar-C), 122.2 (Ar-C), 123.4 (Ar-C), 
127.4 (Ar-C), 136.1 (Ar-C), 169.9 (C=O), 171.0 (C=O), 172.8 (C=O). 
IR Umax /cm-1 (solid) 3274 m (N-H), 3058 w (C-H), 2918 w (C-H), 1735 s (ester C=O), 1640 m 
(amide C=O), 1433 m (C-H), 1340 s (C-O).  














Peptide 4e was synthesised from Ac-Trp-Leu-OMe (SI-8) (0.280 g, 0.75 mmol) using the 
procedure in section 2.3. Purification by flash column chromatography (75% EtOAc/pet. 
ether) followed by recrystallisation from CH2Cl2 / hexanes gave 4e as a white solid (0.464 g, 
98%); m.p. 80-81 °C, Rf 0.21 (75% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 0.85-0.88 (6H, m, Leu-CH3 (x2)), 1.49-1.55 (3H, m, Leu-CH2 / 
Leu-CH), 1.65 (9H, s, Boc-(CH3)3), 1.99 (3H, s, acetyl-CH3), 3.11 (1H, dd, J = 14.5, J = 7.9, 
Trp-CHH), 3.20 (1H, dd, J = 14.5, J = 5.6, Trp-CHH), 3.66 (3H, s, ester-CH3), 4.46-4.51 (1H, 
m, Trp-α-CH), 4.79 (1H, dt, J = 7.6, J = 5.7, Leu-α-CH), 6.36 (1H, d, J = 7.9, Trp-NH), 6.53 
(1H, d, J = 7.6, Leu-NH), 7.23 (1H, t, J = 7.1, Trp-Ar-H), 7.31 (1H, t, J = 7.1, Trp-Ar-H), 7.50 
(1H, br s, Trp-Ar-H), 7.67 (1H, d, J = 7.8, Trp-Ar-H), 8.12 (1H, m, Trp-Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 21.9 (Leu-CH3), 22.7 (Leu-CH3), 23.2 (acetyl-CH3), 24.7 
(Leu-CH), 28.2 (Boc-(CH3)3), 28.2 (Trp-CH2),  41.4 (Leu-CH2), 50.9 (Leu-α-CH), 52.3 (ester-
CH3), 53.2 (Trp-α-CH), 83.6 (Boc-C), 115.2 (Ar-C), 115.3 (Ar-C), 119.1 (Ar-C), 122.7 (Ar-C), 
124.5 (Ar-C), 124.6 (Ar-C), 130.3 (Ar-C), 135.4 (Ar-C), 149.6 (C=O), 170.0 (C=O), 170.7 
(C=O), 172.5 (C=O). 
IR Umax /cm-1 (solid) 3263 m (N-H), 3060 w (C-H), 2955 w (C-H), 1741 s (ester C=O), 1622 m 
(amide C=O), 1541 m (C=C), 1430 m (C-H), 1252 s (C-O).  













3.6.6. Synthesis of Ac-Trp(Boc)-Met-OMe (4f) 
Ac-Trp-Met-OMe 
 
The peptide Ac-Trp-Met-OMe (SI-9) was synthesised from L-methionine methyl ester 
hydrochloride (0.499 g, 2.50 mmol) and N-acetyl-L-tryptophan (0.246 g, 1.00 mmol), using 
the procedure in section 2.1. The crude compound was recrystallised from CH2Cl2 / 
hexanes to afford SI-9 as a yellow solid (0.348 g, 89%); m.p. 126-127 °C. 
1H NMR (400 MHz, CDCl3) δ 1.76-1.81 (1H, m, Met-CHH), 1.87 (3H, s, Met-CH3), 1.92-1.98 
(4H, m, acetyl-CH3 / Met-CHH), 2.27 (2H, d, J = 7.7, Met-CH2), 3.10 (1H, dd, J = 14.6, J = 
7.6, Trp-CHH), 3.20 (1H, dd, J = 14.6, J = 5.4, Trp-CHH), 3.56 (3H, s, ester-CH3), 4.48 (1H, 
dt, J = 7.6, J = 5.4, Met-α-CH), 4.73 (1H, dt, J = 7.4, J = 5.4, Trp-α-CH), 6.50 (1H, d, J = 7.7, 
Met-NH), 6.71 (1H, d, J = 7.4, Trp-NH), 7.00-7.03 (2H, m, Trp-Ar-H), 7.09 (1H, t, J = 7.5, 
Trp-Ar-H), 7.26 (1H, d, J = 7.5, Trp-Ar-H), 7.56 (1H, d, J = 7.5, Trp-Ar-H), 8.47 (1H, br s, Trp-
Ar-NH). 
13C{1H} NMR (100 MHz, CDCl3) δ 15.2 (Met-CH3), 23.1 (acetyl-CH3), 28.3 (Met-CH2), 29.6 
(Met-CH2), 31.2 (Trp-CH2), 51.5 (Trp-α-CH), 52.4 (ester-CH3), 53.9 (Met-α-CH), 110.1 (Ar-
C), 111.2 (Ar-C), 118.5 (Ar-C), 119.5 (Ar-C), 122.0 (Ar-C), 123.4 (Ar-C), 124.4 (Ar-C), 136.1 
(Ar-C), 170.2 (C=O), 171.4 (C=O), 171.7 (C=O). 
IR Umax /cm-1 (solid) 3291 m (N-H), 3054 w (C-H), 2914 w (C-H), 1743 s (ester C=O), 1631 m 
(amide C=O), 1431 m (C-H), 1224 s (C-O).  















Peptide 4f was synthesised from Ac-Trp-Met-OMe (SI-9) (0.294 g, 0.75 mmol) using the 
procedure in section 2.3. Purification by flash column chromatography (75% EtOAc/pet. 
ether) followed by recrystallisation from CH2Cl2 / hexanes gave 4f as a white solid (0.398 g, 
81%); m.p. 154-155 °C, Rf 0.19 (75% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.66 (9H, s, Boc-(CH3)3), 1.87-1.94 (1H, m, Met-CHH), 2.00-
2.09 (7H, m, Met-CHH / Met-CH3 / acetyl-CH3), 2.38 (1H, br t, J = 7.3, Met-CH2), 3.10 (1H, 
dd, J = 14.4, J = 8.0, Trp-CHH), 3.22 (1H, dd, J = 14.4, J = 5.5, Trp-CHH), 3.66 (3H, s, ester-
CH3), 4.55 (1H, dt, J = 7.3, J = 5.0, Met-α-CH), 4.77 (1H, dt, J = 8.0, J = 5.5, Trp-α-CH), 6.49 
(1H, d, J = 7.3, Met-NH), 6.57 (1H, d, J = 8.0, Trp-NH), 7.23 (1H, t, J = 7.5, Trp-Ar-H), 7.31 
(1H, t, J = 7.5, Trp-Ar-H), 7.49 (1H, s, Trp-Ar-H), 7.65 (1H, d, J = 7.5, Trp-Ar-H), 8.10 (1H, m, 
Trp-Ar-H),       
13C{1H} NMR (100 MHz, CDCl3) δ 15.3 (Met-CH3), 23.2 (acetyl-CH3), 28.1 (Boc-(CH3)3), 28.2 
(Trp-CH2), 29.7 (Met-CH2), 31.3 (Met-CH2), 51.6 (Trp-α-CH), 52.5 (ester-CH3), 53.3 (Met-α-
CH),  83.6 (Boc-C), 115.1 (Ar-C), 115.2 (Ar-C), 119.0 (Ar-C), 122.7 (Ar-C), 124.5 (Ar-C), 
124.6 (Ar-C), 130.1 (Ar-C), 135.4 (Ar-C), 149.5 (C=O), 170.0 (C=O), 170.7 (C=O), 171.4 
(C=O).   
IR Umax /cm-1 (solid) 3291 m (N-H), 3055 w (C-H), 2915 w (C-H), 1743 s (ester C=O), 1631 m 
(amide C=O), 1431 m (C-H), 1224 s (C-O).  














3.6.7. Synthesis of Ac-Gly-Leu-Trp(Boc)-OMe (4g) 
Ac-Gly-Leu-Trp-OMe (SI-10) 
 
The peptide Ac-Gly-Leu-Trp-OMe (SI-10) was synthesised from Ac-Gly-Leu-OMe (0.241 g, 
0.80 mmol) and L-tryptophan methyl ester hydrochloride (0.509 g, 2.00 mmol), using the 
procedure in section 2.2. Purification by trituration (Et2O) afforded SI-10 as a white solid 
(0.255 g, 74%); m.p. 144-146 °C. 
1H NMR (400 MHz, CDCl3) δ 0.86 (3H, d, J = 9.5, Leu-CH3), 0.88 (3H, d, J = 9.5, Leu-CH3), 
1.48-1.50 (1H, m, Leu-CHH), 1.57-1.63 (1H, m, Leu-CHH), 1.70-1.76 (1H, m, Leu-
CH(CH3)2), 1.91 (3H, s, acetyl-CH3), 3.24 (1H, dd, J = 14.9, J = 6.3, Trp-CHH), 3.31 (1H, dd, 
J = 14.9, J = 5.0, Trp-CHH), 3.66-3.72 (1H, m, Gly-CHH), 3.70 (3H, s, ester-CH3), 3.80 (1H, 
dd, J = 16.8, J = 5.6, Gly-CHH), 4.58-4.60 (1H, m, Leu-α-CH), 4.88-4.93 (1H, m, Trp-α-CH), 
6.28 (1H, br t, J = 5.3, Gly-NH), 6.70 (1H, br d, J = 8.6, Leu-NH), 6.98 (1H, m, Trp-Ar-H), 
7.05-7.10 (2H, m, Trp-Ar-H / Trp-NH), 7.16 (1H, t, J = 7.4, Trp-Ar-H), 7.32 (1H, d, J = 7.4, 
Trp-Ar-H), 7.50 (1H, d, J = 7.4, Trp-Ar-H), 8.66 (1H, s, Trp-Ar-NH).   
13C{1H} NMR (100 MHz, CDCl3) δ 21.9 (Leu-CH3 (x2)), 22.8 (acetyl-CH3), 24.7 (Leu-CH), 
27.5 (Trp-CH2), 41.0 (Leu-CH2), 42.8 (Gly-CH2), 51.6 (Leu-α-CH), 52.5 (ester-CH3), 52.7 
(Trp-α-CH), 109.3 (Ar-C), 111.4 (Ar-C), 118.3 (Ar-C), 119.4 (Ar-C), 122.1 (Ar-C), 123.4 (Ar-
C), 127.4 (Ar-C), 136.0 (Ar-C),169.0 (C=O), 171.0 (C=O), 171.9 (C=O), 172.2 (C=O).  
IR Umax /cm-1 (solid) 3282 m (N-H), 3055 w (C-H), 2928 w (C-H), 1739 s (ester C=O), 1631 m 
(amide C=O), 1431 m (C-H). 

















Peptide 4g was synthesised from Ac-Gly-Leu-Trp-OMe (SI-10) (0.237 g, 0.55 mmol) using 
the procedure in section 2.3. Purification by flash column chromatography (EtOAc) followed 
by recrystallisation from CH2Cl2 / hexanes gave 4g as a white solid. (0.181 g, 62%); m.p. 
116-118 °C, Rf 0.10 (EtOAc).  
1H NMR (400 MHz, CDCl3) δ 0.88 (3H, d, J = 10.0, Leu-CH3), 0.91 (3H, d, J = 10.0, Leu-
CH3), 1.46-1.52 (1H, m, Leu-CH), 1.55-1.64 (2H, m, Leu-CH2), 1.68 (9H, s, Boc-(CH3)3), 2.01 
(3H, s, acetyl-CH3), 3.19 (1H, dd, J = 14.8, J = 6.3, Trp-CHH), 3.27 (1H, dd, J = 14.8, J = 
6.3, Trp-CHH), 3.68 (3H, s, ester-CH3), 3.80-3.92 (2H, m, Gly-CH2), 4.42-4.48 (1H, m, Leu-
α-CH), 4.88 (1H, dt, J = 7.4, J = 6.3, Trp-α-CH), 6.86-6.71 (2H, m, Gly-NH / Leu-NH), 6.94 
(1H, d, J = 7.4, Trp-NH), 7.22 (1H, t, J = 7.4, Trp-Ar-H), 7.30 (1H, t, J = 7.4, Trp-Ar-H), 7.42 
(1H, s, Trp-Ar-H), 7.48 (1H, d, J = 7.4, Trp-Ar-H), 8.05 (1H, br d, Trp-Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 21.9 (Leu-CH3), 22.8 (acetyl-CH3), 24.6 (Leu-CH), 27.2 
(Trp-CH2), 28.2 (Boc-(CH3)3), 40.4 (Leu-CH2), 43.2 (Gly-CH2), 51.7 (Leu-α-CH), 52.4 (ester-
CH3), 52.5 (Trp-α-CH), 84.0 (Boc-C), 114.9 (Ar-C), 115.3 (Ar-C), 118.8 (Ar-C), 122.6 (Ar-C), 
124.3 (Ar-C), 124.5 (Ar-C), 130.4 (Ar-C), 135.1 (Ar-C), 149.9 (C=O), 169.2 (C=O), 170.9 
(C=O), 171.5 (C=O), 172.7 (C=O). 
IR Umax /cm-1 (solid) 3278 m (N-H), 3060 w (C-H), 2954 w (C-H), 1731 s (ester C=O), 1631 m 
(amide C=O), 1451 m (C-H), 1226 s (C-O).  













3.6.8. Synthesis of Ac-Leu-Trp(Boc)-Leu-OMe (4h) 
Ac-Leu-Trp-Leu-OMe (SI-11) 
 
The peptide Ac-Leu-Trp-Leu-OMe (SI-11) was synthesised from Ac-Leu-Trp-OMe (0.299 g, 
0.80 mmol) and L-leucine methyl ester hydrochloride (0.363 g, 2.00 mmol), using the 
procedure in section 2.2. Purification by trituration (Et2O) afforded SI-11 as a white solid 
(0.343 g, 88%); m.p. 212-215 °C. 
1H NMR (400 MHz, CDCl3) δ 0.83-0.85 (6H, m, Leu-CH3 (x2)), 0.91 (6H, m, Leu-CH3 (x2)), 
1.37-1.69 (6H, m, Leu-CH (x2) / Leu-CH2 (x2)), 1.79 (3H, s, acetyl-CH3), 3.17 (1H, dd, J = 
14.6, J = 7.6, Trp-CHH), 3.36 (1H, dd, J = 14.6, J = 5.4, Trp-CHH), 3.67 (3H, s, ester-CH3), 
4.36-4.42 (1H, m, Leu-α-CH), 4.47 (1H, dt, J = 8.4, J = 5.0, Leu-α-CH), 4.73 (1H, dt, J = 7.6, 
J = 5.4, Trp-α-CH), 5.69 (1H, d, J = 7.8, Leu-NH), 6.22 (1H, d, J = 8.4, Leu-NH), 6.70 (1H, d, 
J = 7.6, Trp-NH), 7.13-7.16 (2H, m, Trp-Ar-H), 7.21 (1H, J = 8.0, Trp-Ar-H), 7.38 (1H, d, J = 
8.0, Trp-Ar-H), 7.72 (1H, d, J = 8.0, Trp-Ar-H), 8.14 (1H, br s, Trp-Ar-NH).   
13C{1H} NMR (100 MHz, CD3OD) δ 21.8 (Leu-CH3), 21.9 (Leu-CH3), 22.3 (acetyl-CH3), 23.3 
(Leu-CH3), 23.3 (Leu-CH3), 25.7 (Leu-CH), 25.8 (Leu-CH), 28.4 (Trp-CH2), 41.4 (Leu-CH2), 
41.5 (Leu-CH2), 52.1 (Leu-α-CH), 52.6 (ester-CH3), 53.4 (Trp-α-CH), 55.2 (Leu-α-CH), 110.6 
(Ar-C), 112.2 (Ar-C), 119.3 (Ar-C), 119.8 (Ar-C), 122.3 (Ar-C), 124.7 (Ar-C), 128.9 (Ar-C), 
138.0 (Ar-C), 173.5 (Ar-C), 173.8 (Ar-C), 174.3 (Ar-C), 147.5 (Ar-C).  
IR Umax /cm-1 (solid) 3290 m (N-H), 3068 w (C-H), 2956 w (C-H), 1741 s (ester C=O), 1629 m 
(amide C=O), 1430 m (C-H), 1220 s (C-O).  

















Peptide 4h was synthesised from Ac-Leu-Trp-Leu-OMe (SI-11) (0.268 g, 0.55 mmol) using 
the procedure in section 2.3. Purification by flash column chromatography (EtOAc) followed 
by recrystallisation from CH2Cl2 / hexanes gave 4h as a white solid. (0.287 g, 89%); m.p. 
180-184 °C, Rf 0.14 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 0.84-0.91 (12H, m, Leu-CH3 (x4)), 1.42-1.61 (6H, m, Leu-CH 
(x2) / Leu-CH2 (x2)), 1.66 (9H, s, Boc-(CH3)3), 1.90 (3H, s, acetyl-CH3), 3.11-3.24 (2H, m, 
Trp-CH2), 3.65 (3H, s, ester-CH3), 4.43-4.52 (2H, m, Leu-α-CH (x2)), 4.73-4.79 (1H, m, Trp-
α-CH), 5.95 (1H, br d, J = 7.3, Leu-NH), 6.43 (1H, br d, J = 8.7, Trp-NH), 6.90 (1H, br d, J = 
7.8, Leu-NH), 7.24-7.34 (2H, m, Trp-Ar-H), 7.49 (1H, s, Trp-Ar-H), 7.64 (1H, d, J = 7.8, Trp-
Ar-H), 8.11 (1H, m, Trp-Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 21.8 (Leu-CH3), 22.1 (Leu-CH3), 22.7 (Leu-CH3), 22.8 
(Leu-CH3), 22.9 (acetyl-CH3), 24.7 (Leu-CH), 24.7 (Leu-CH), 27.7 (Trp-CH2), 28.2 (Boc-
(CH3)3), 41.1 (Leu-CH2), 41.2 (Leu-CH2), 50.8 (Leu-α-CH), 51.8 (Trp-α-CH), 52.2 (ester-
CH3), 53.0 (Leu-α-CH), 83.7 (Boc-C), 115.2 (Ar-C), 115.3 (Ar-C), 119.1 (Ar-C), 122.7 (Ar-C), 
124.5 (Ar-C), 124.6 (Ar-C), 130.1 (Ar-C), 135.4 (Ar-C), 149.6 (C=O), 170.2 (C=O), 170.3 
(C=O), 172.0 (C=O), 172.6 (C=O). 
IR Umax /cm-1 (solid) 3254 m (N-H), 3073 w (C-H), 2957 w (C-H), 1720 s (ester C=O), 1631 m 
(amide C=O), 1545 m (C=C), 1439 m (C-H), 1291 s (C-O).  














3.6.9. Synthesis of Ac-Met-Trp(Boc)-Met-OMe (4i) 
Ac-Met-Trp-Met-OMe (SI-12) 
 
The peptide Ac-Met-Trp-Met-OMe (SI-12) was synthesised from Ac-Met-Trp-OMe (SI-6) 
(0.313 g, 0.80 mmol) and L-methionine methyl ester hydrochloride (0.399 g, 0.80 mmol), 
using the procedure in section 2.2. Purification by trituration (Et2O) afforded SI-12 as a 
white solid (0.335 g, 80%); m.p. 191-193 °C. 
1H NMR (400 MHz, CDCl3) δ 1.77 (3H, s, Met-CH3), 1.89-1.97 (2H, m, Met-CH2), 2.00 (3H, 
s, acetyl-CH3), 2.03-2.06 (2H, m, Met-CH2), 2.09 (3H, s, Met-CH3), 2.23-2.29 (2H, m, Met-
CH2), 2.49-2.61 (2H, m, Met-CH2), 3.17 (1H, dd, J = 14.5, J = 7.0, Trp-CHH), 3.39 (1H, dd, J 
= 14.5, J = 5.5, Trp-CHH), 3.68 (3H, s, ester-CH3), 4.51-4.60 (2H, m, Met-α-CH (x2)), 4.73-
4.78 (1H, m, Trp-α-CH), 6.40 (1H, d, J = 7.3, Met-NH), 6.68 (1H, d, J = 7.8, Met-NH), 6.92 
(1H, d, J = 7.7, Trp-NH), 7.10 (1H, d, J = 2.3, Trp-Ar-H), 7.12-7.16 (1H, m, Trp-Ar-H), 7.18-
7.22 (1H, m, Trp-Ar-H), 7.37 (1H, d, J = 7.6, Trp-Ar-H), 7.64 (1H, d, J = 7.6, Trp-Ar-H), 8.27 
(1H, br s, Trp-Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 15.2 (Met-CH3), 15.3 (Met-CH3), 22.8 (acetyl-CH3), 27.7 
(Trp-CH2), 29.6 (Met-CH2), 30.2 (Met-CH2), 30.8 (Met-CH2), 31.0 (Met-CH2), 51.5 (Met-α-
CH), 52.5 (ester-CH3), 52.9 (Met-α-CH), 54.0 (Trp-α-CH), 109.8 (Ar-C), 111.4 (Ar-C), 118.6 
(Ar-C), 119.8 (Ar-C), 122.3 (Ar-C), 123.8 (Ar-C), 127.4 (Ar-C), 136.2 (Ar-C), 170.5 (C=O), 
170.8 (C=O), 171.8 (C=O), 172.3 (C=O). 
IR Umax /cm-1 (solid) 3254 m (N-H), 3070 w (C-H), 2915 w (C-H), 17437 s (ester C=O), 1627 
m (amide C=O), 1436 m (C-H), 1224 s (C-O).  


















Peptide 4i was synthesised from Ac-Met-Trp-Met-OMe (SI-12) (0.268 g, 0.55 mmol) using 
the procedure in section 2.3. Purification by flash column chromatography (EtOAc) followed 
by recrystallisation from CH2Cl2 / hexanes gave 4i as a white solid. (0.287 g, 87%); m.p. 
180-184 °C, Rf 0.35 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.63 (9H, s, Boc-(CH3)3), 1.88 (1H, dd, J = 14.6, J = 7.3 Met-
CHH), 1.92-1.94 (4H, m, Met-CH3 / Met-CHH), 1.96-1.99 (4H, m, Met-CH3 / Met-CHH), 2.01-
2.04 (4H, m, acetyl-CH3 / Met-CHH), 2.33 (2H, t, J = 7.3, Met-CH2), 2.46-2.51 (2H, m, Met-
CH2), 3.09-3.20 (2H, m, Trp-CH2), 3.64 (3H, s, ester-CH3), 4.54 (1H, dt, J = 7.3, J = 5.0, Met-
α-CH), 4.66 (1H, dt, J = 7.3, J = 6.8, Met-α-CH),  4.82 (1H, dt, J = 7.5, J = 6.8, Trp-α-CH), 
6.68 (1H, d, J = 7.8, Met-NH), 6.99 (1H, d, J = 7.8, Met-NH), 7.18 (1H, t, J = 7.8, Trp-Ar-H), 
7.25-7.30 (2H, m, Trp-Ar-H / Trp-NH), 7.48 (1H, s, trp-Ar-H), 7.53 (1H, d, J = 7.8, Trp-Ar-H), 
8.06 (1H, m, Trp-Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 15.2 (Met-CH3), 15.3 (Met-CH3), 23.0 (acetyl-CH3), 28.0 
(Trp-CH2), 28.1 (Boc-(CH3)3), 29.7 (Met-CH2), 30.0 (Met-CH2), 31.2 (Met-CH2), 31.5 (Met-
CH2), 51.5 (Met-α-CH), 52.3 (ester-CH3), 52.4 (Met-α-CH), 53.3 (Trp-α-CH), 83.6 (Boc-C), 
115.0 (Ar-C), 115.2 (Ar-C), 118.9 (Ar-C), 122.6 (Ar-C), 124.5 (Ar-C), 124.6 (Ar-C), 130.1 (Ar-
C), 135.4 (Ar-C), 149.5 (C=O), 170.3 (C=O), 170.5 (C=O), 171.1 (C=O), 171.6 (C=O). 
IR Umax /cm-1 (solid) 3260 m (N-H), 3069 w (C-H), 2919 w (C-H), 1728 s (ester C=O), 1631 m 
(amide C=O), 1453 m (C-H), 1224 s (C-O).  


















3.6.10. Synthesis of Ac-Trp-Leu-Leu-OMe (4j) 
Ac-Trp-Leu-Leu-OMe (SI-13) 
 
The peptide Ac-Trp-Leu-Leu-OMe (SI-13) was synthesised from Ac-Trp-Leu-OMe (SI-8) 
(0.299 g, 0.80 mmol) and L-leucine methyl ester hydrochloride (0.363 g, 2.00 mmol), using 
the procedure in section 2.2. Purification by trituration (Et2O) afforded SI-13 as a white solid 
(0.370 g, 95%); m.p.187-188 °C, 
1H NMR (400 MHz, CDCl3) δ 0.83-0.86 (6H, m, Leu-(CH3)2), 0.92-0.94 (6H, m, Leu-(CH3)2), 
1.36-1.43 (1H, m, Leu-CHH), 1.48-1.55 (2H, m, Leu-CHH / Leu-CH(CH3)2),  1.58-1.65 (3H, 
m, Leu-CH2 / Leu-CH(CH3)2), 1.97 (3H, s, acetyl-CH3), 3.15 (1H, dd, J = 14.6, J = 7.4, Trp-
CHH), 3.28 (1H, dd, J = 14.6, J = 6.0, Trp-CHH), 3.73 (3H, s, ester-CH3), 4.40 (1H, m, Leu-
α-CH), 4.56 (1H, dt, J = 8.4, J = 5.0, Leu-α-CH), 4.78 (1H, app q, J = 6.0, Trp-α-CH), 6.35-
6.41 (2H, m, Leu-NH / Trp-NH), 6.54 (1H, d, J = 8.4, Leu-NH), 7.08 (1H, m, Trp-Ar-H), 7.14 
(1H, t, J = 7.9, Trp-Ar-H), 7.21 (1H, t, J = 7.9, Trp-Ar-H), 7.36 (1H, d, J = 7.9, Trp-Ar-H), 7.72 
(1H, d, J = 7.9, Ar-H), 8.23 (1H, br s, Trp-NH).  
13C{1H} NMR (100 MHz, CDCl3) δ 21.9 (Leu-CH3), 22.0 (Leu-CH3), 22.7 (Leu-CH3), 22.8 
(Leu-CH3), 23.2 (acetyl-CH3), 24.6 (Leu-CH2), 24.8 (Leu-CH2), 28.1 (Trp-CH2), 40.8 (Leu-
CH), 41.2 (Leu-CH), 50.7 (Leu-α-CH), 52.0 (Trp-α-CH), 52.3 (ester-CH3), 53.8 (Leu-α-CH), 
110.4 (Ar-C), 111.3 (Ar-C), 118.8 (Ar-C), 119.8 (Ar-C), 122.4 (Ar-C), 123.3 (Ar-C), 127.4 (Ar-
C), 136.2 (Ar-C), 170.2 (C=O), 171.4 (C=O), 171.4 (C=O), 173.2 (C-O).  
IR Umax /cm-1 (solid) 382 m (N-H), 3029 w (C-H), 2988 w (C-H), 1739 s (ester C=O), 1632 m 
(amide C=O), 1221 s (C-O).  
















Peptide 4j was synthesised from Ac-Trp-Leu-Leu-OMe (SI-13) (0.268 g, 0.55 mmol) using 
the procedure in section 2.3. Purification by flash column chromatography (EtOAc) followed 
by recrystallisation from CH2Cl2 / hexanes gave 4j as a white solid. (0.284 g, 88%); m.p. 
198-199 °C, Rf 0.16 (EtOAc). 
1H NMR (400 MHz, CD3OD) δ 0.88-0.95 (12H, m, Leu-CH3 (x4)), 1.52-1.63 (6H, m, Leu-CH 
(x2) / Leu-CH2 (x2)), 1.67 (9H, s, Boc-(CH3)3), 1.91 (3H, s, acetyl-CH3), 3.00 (1H, dd, J = 
15.0, J = 8.2, Trp-CHH), 3.22 (1H, dd, J = 15.0, J = 5.1, Trp-CHH), 3.69 (3H, s, ester-CH3), 
4.39-4.45 (2H, m, Leu-α-CH (x2)), 4.71-4.75 (1H, m, Trp-α-CH), 7.21-7.24 (1H, m, Trp-Ar-H), 
7.26-7.30 (1H, m, Trp-Ar-H), 7.51 (1H, s, Trp-Ar-H), 7.65 (1H, d, J = 8.0, Trp-Ar-H), 8.07 
(1H, br d, J = 8.0, Trp-Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 21.9 (Leu-CH3), 22.1 (Leu-CH3), 22.6 (Leu-CH3), 22.7 
(Leu-CH3), 23.0 (acetyl-CH3), 24.5 (Leu-CH), 24.9 (Leu-CH), 27.6 (Trp-CH2), 28.2 (Boc-
(CH3)3), 41.0 (Leu-CH2), 41.1 (Leu-CH2), 50.8 (Leu-α-CH), 51.9 (Trp-α-CH), 52.2 (ester-
CH3), 53.1 (Leu-α-CH), 83.8 (Boc-C), 115.2 (Ar-C), 115.3 (Ar-C), 118.9 (Ar-C), 122.7 (Ar-C), 
124.3 (Ar-C), 124.5 (Ar-C), 130.3 (Ar-C), 135.3 (Ar-C), 149.7 (C=O), 170.4 (C=O), 171.3 
(C=O), 171.5 (C=O), 173.1 (C=O). 
IR Umax /cm-1 (solid) 3297 m (N-H), 2960 w (C-H), 1750 s (ester C=O), 1628 m (amide C=O), 
1246 s (C-O).  















3.7. Synthesis of modified peptides 5a-j 
Synthesis of modified peptide 5a 
 
Modified peptide 5a was prepared from Ac-Ala-Trp(Boc)-OMe (4a) (0.103 g, 0.238 mmol) 
and styrene (0.109 mL, 0.952 mmol), using the general procedure in section 2.4. As judged 
by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-olefinated 
peptide 5a and a di-olefinated peptide in a ratio of 14:1. Purification by flash column 
chromatography (75% EtOAc/pet. ether) followed by recrystallisation from CH2Cl2 / hexanes 
gave 5a as an off-white solid (0.086 g, 68%); m.p. 93-95 °C, Rf 0.26 (75% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.20 (3H, d, J = 7.0, Ala-CH3), 1.56 (9H, s, Boc-(CH3)3), 1.79 
(3H, s, acetyl-CH3), 3.25-3.36 (2H, m, Trp-CH2), 3.48 (3H, s, ester-CH3), 4.33 (1H, dq, J = 
7.4, J = 7.0, Ala-α-CH), 4.81 (1H, dt, J = 7.8, J = 7.3, Trp-α-CH), 5.82 (1H, br d, J = 7.4, Ala-
NH), 6.51 (1H, br d, J = 7.8, Trp-NH), 6.69 (1H, d, J = 16.7, alkene-CH), 7.15-7.27 (4H, m, 
Ar-H/alkene-CH), 7.31 (2H, t, J = 7.4, Ar-H), 7.48 (3H, d, J = 7.4, Ar-H), 8.06 (1H, d, J = 8.2, 
Ar-H).     
13C{1H} NMR (100 MHz, CDCl3) δ 18.3 (Ala-CH3), 23.1 (acetyl-CH3), 27.5 (Trp-CH2), 28.2 
(Boc-(CH3)3), 48.5 (Ala-α-CH), 52.5 (ester-CH3), 52.6 (Trp-α-CH), 84.1 (Boc-C), 114.4 (Ar-
C), 115.6 (Ar-C), 118.7 (Ar-C), 119.3 (alkene-CH), 122.8 (Ar-C), 124.7 (Ar-C), 126.5 (Ar-C), 
128.0 (Ar-C), 128.7 (Ar-C), 129.9 (Ar-C), 132.4 (alkene-CH), 135.8 (Ar-C), 136.2 (Ar-C), 
136.7 (Ar-C), 150.3 (C=O), 169.7 (C=O), 171.8 (C=O), 171.9 (C=O). 
IR Umax /cm-1 (solid) 3281 m (N-H), 3036 w (C-H), 2928 w (C-H), 1725 s (ester C=O), 1631 m 
(amide C=O), 1541 m (C=C), 1448 m (C-H), 1221 s (C-O).  













Synthesis of modified peptide 5b 
 
Modified peptide 5b was prepared from Ac-Leu-Trp(Boc)-OMe (4b) (0.113 g, 0.238 mmol) 
and styrene (0.109 mL, 0.952 mmol), using the general procedure in section 2.4. As judged 
by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-olefinated 
peptide 5b and a di-olefinated peptide in a ratio of 19:1. Purification by flash column 
chromatography (50% EtOAc/pet. ether) followed by recrystallisation from CH2Cl2 / hexanes 
gave 5b as an off-white solid (0.085 g, 62%); m.p. 97-98°C, Rf 0.22 (50% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 0.86-0.88 (6H, m, Leu-CH3 (x2)), 1.37-1.41 (1H, m, Leu-CH), 
1.54-1.59 (2H, m, Leu-CH2), 1.63 (9H, s, Boc-(CH3)3), 1.87 (3H, s, acetyl-CH3), 3.31-3.43 
(2H, m, Trp-CH2), 3.57 (3H, s, ester-CH3), 4.41 (1H, dt, J = 8.6, J = 5.4, Leu-α-CH), 4.87 
(1H, app q, J = 7.2, Trp-α-CH), 5.66 (1H, br d, J = 8.6, Leu-NH), 6.51 (1H, br d, J = 7.7, Trp-
NH), 6.75 (1H, d, J = 16.6, alkene-CH), 7.24-7.33 (5H, m, Ar-H / alkene-CH), 7.39 (2H, t, J = 
7.4, Ar-H), 7.56-7.58 (2H, m, Ar-H), 8.13 (1H, d, J = 8.3, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.0 (Leu-CH3), 22.8 (Leu-CH3), 23.1 (acetyl-CH3), 24.6 
(Leu-CH), 27.7 (Trp-CH2), 28.3 (Boc-(CH3)3), 41.2 (Leu-CH2), 51.3 (Leu-α-CH), 52.5 (ester-
CH3), 52.5 (Trp-α-CH), 84.0 (Boc-C), 114.5 (Ar-C), 115.6 (Ar-C), 118.7 (Ar-C), 120.0 
(alkene), 122.9 (Ar-C), 124.7 (Ar-C), 126.6 (Ar-C), 128.0 (Ar-C), 128.7 (Ar-C), 129.9 (Ar-C), 
132.4 (alkene), 135.8 (Ar-C), 136.2 (Ar-C), 136.8 (Ar-C), 150.4 (C=O), 169.8 (C=O), 171.7 
(C=O), 172.0 (C=O).  
IR Umax /cm-1 (solid) 3268 m (N-H), 2927 w (C-H), 1728 s (ester C=O), 1647 m (amide C=O), 
1451 m (C-H), 1255 s (C-O).  












Synthesis of modified peptide 5c 
 
Modified peptide 5c was prepared from Ac-Met-Trp(Boc)-OMe (4c) (0.117 g, 0.238 mmol) 
and styrene (0.109 mL, 0.952 mmol), using the general procedure in section 2.4. As judged 
by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-olefinated 
peptide 5c and a di-olefinated peptide in a ratio of 8.1. Purification by flash column 
chromatography (50% EtOAc/pet. ether) followed by recrystallisation from CH2Cl2 / hexanes 
gave 5c as an off-white solid (0.105 g, 74%); m.p. 94-96°C, Rf 0.15 (50% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.63 (9H, s, Boc-(CH3)3), 1.86-1.90 (4H, m, Met-CHH / acetyl-
CH3), 1.93-1.97 (1H, m, Met-CH), 2.00 (3H, s, Met-CH3), 2.47-2.53 (2H, m, Met-CH2), 3.35 
(1H, dd, J = 14.5, J = 6.9, Trp-CHH), 3.41 (1H, dd, J = 14.5, J = 6.9, Trp-CHH), 3.59 (3H, s, 
ester-CH3), 4.54 (1H, dt, J = 7.3, J = 7.0, Met-α-CH), 4.87 (1H, dt, J = 7.3, J = 6.9, Trp-α-
CH), 6.11 (1H, d, J = 7.3, Met-NH), 6.73-6.78 (2H, m, alkene-CH / Ar-H), 7.25-7.32 (3H, m, 
alkene-CH / Ar-H), 7.36-7.40 (2H, m, Ar-H), 7.54-7.57 (3H, m, Ar-H), 8.14 (1H, d, J = 8.4, Ar-
H). 
13C{1H} NMR (100 MHz, CDCl3) δ 14.8 (Met-CH3), 23.1 (acetyl-CH3), 27.4 (Trp-CH2), 28.2 
(Boc-(CH3)3), 29.8 (Met-CH2), 31.4 (Met-CH2), 51.6 (Met-α-CH), 52.5 (ester-CH3), 52.6 (Trp-
α-CH), 84.1 (Boc-C), 114.2 (Ar-C), 115.6 (Ar-C), 118.6 (Ar-C), 120.0 (alkene-CH), 122.9 (Ar-
C), 124.8 (Ar-C), 126.6 (Ar-C), 128.1 (Ar-C), 128.7 (Ar-C), 129.7 (Ar-C), 132.6 (alkene-CH), 
135.8 (Ar-C), 136.2 (Ar-C), 136.7 (Ar-C), 150.3 (C=O), 169.7 (C=O), 170.7 (C=O), 171.8 
(C=O). 
IR Umax /cm-1 (solid) 3282 m (N-H), 3060 w (C-H), 2927 w (C-H), 1743 s (ester C=O), 1646 m 
(amide C=O), 1459 m (C-H).  















Synthesis of modified peptide 5d 
 
Modified peptide 5d was prepared from Ac-Phe-Trp(Boc)-OMe (4d) (0.121 g, 0.238 mmol) 
and styrene (0.109 mL, 0.952 mmol), using the general procedure in section 2.4. As judged 
by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-olefinated 
peptide 5d and a di-olefinated tryptophan residue in a ratio of 12:1. Purification by flash 
column chromatography (50% EtOAc/pet. ether) followed by recrystallisation from CH2Cl2 / 
hexanes gave 5d as an off-white solid (0.075 g, 52%); m.p. 150-151 °C, Rf 0.31 (50% 
EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.62 (9H, s, Boc-(CH3)3), 1.82 (3H, s, acetyl-CH3), 2.92 (1H, 
dd, J = 13.7, J = 7.8, Phe-CHH), 3.00 (1H, dd, J = 13.7, J = 6.0, Phe-CHH), 3.23-3.33 (2H, 
m, Trp-CH2), 3.50 (3H, s, ester-CH3), 4.53-4.59 (1H, m, Phe-α-CH), 4.80 (1H, app q, J = 7.3, 
Trp-α-CH), 5.59-5.62 (1H, m, Phe-NH), 6.19-6.22 (1H, m, Trp-NH), 6.71 (1H, d, J = 16.5, 
alkene-CH), 7.13-7.25 (6H, m, Ar-H), 7.26-7.30 (3H, m, Ar-H / alkene-CH), 7.35-7.42 (3H, m, 
Ar-H), 7.53 (2H, d, J = 7.3, Ar-H), 8.11 (1H, d, J = 8.2, Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 23.2 (acetyl-CH3), 27.7 (Trp-CH2), 28.4 (Boc-(CH3)3), 38.4 
(Phe-CH2), 52.6 (ester-CH3), 52.7 (Trp-α-CH), 54.4 (Phe-α-CH), 84.2 (Boc-C), 114.4 (Ar-C), 
115.7 (Ar-C), 118.7 (Ar-C), 120.0 (alkene-CH), 123.0 (Ar-C), 124.9 (Ar-C), 126.7 (Ar-C), 
127.1 (Ar-C), 128.1 (Ar-C), 128.7 (Ar-C), 128.9 (Ar-C), 129.4 (Ar-C), 130.0 (Ar-C), 132.5 
(alkene-CH), 135.9 (Ar-C), 136.2 (Ar-C), 136.5 (Ar-C), 136.9 (Ar-C), 150.5 (C=O), 169.9 
(C=O), 170.5 (C=O), 171.6 (C=O). 
IR Umax /cm-1 (solid) 3238 m (N-H), 3058 w (C-H), 2950 w (C-H), 1749 s (ester C=O), 1638 m 
(amide C=O), 1523 m (C=C), 1213 s (C-O).  












Synthesis of modified peptide 5e 
 
Modified peptide 5e was prepared from Ac-Trp(Boc)-Leu-OMe (4e) (0.113 g, 0.238 mmol) 
and styrene (0.109 mL, 0.952 mmol), using the general procedure in section 2.4. As judged 
by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-olefinated 
peptide 5e and a di-olefinated peptide in a ratio of 14:1. Purification by flash column 
chromatography (50% EtOAc/pet. ether) followed by recrystallisation from CH2Cl2 / hexanes 
gave 5e as an off-white solid (0.064 g, 47%); m.p. 94-97 °C, Rf 0.38 (50% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 0.81-0.86 (6H, m, Leu-CH3 (x2)), 1.31-1.41 (1H, m, Leu-CH), 
1.43-1.47 (2H, m, Leu-CH2), 1.65 (9H, s, Boc-(CH3)3), 2.00 (3H, s, acetyl-CH3), 3.20 (1H, dd, 
J = 14.0, J = 9.7, Trp-CHH), 3.33 (1H, dd, J = 14.0, J = 5.6, Trp-CHH), 3.50 (3H, s, ester-
CH3), 4.42 (1H, dt, J = 8.3, J = 5.6, Trp-α-CH), 4.77-4.83 (1H, m, Leu-α-CH), 5.78 (1H, d, J = 
8.3, Trp-NH), 6.55 (1H, d, J = 7.6, Leu-NH), 6.79 (1H, d, J= 16.6, alkene-CH), 7.25-7.34 (4H, 
m, alkene-CH / Ar-H), 7.35-7.39 (2H, m, Ar-H), 7.58 (2H, d, J = 7.1, Ar-H), 7.74 (1H, d, J = 
7.1, Ar-H), 8.13 (1H, d, J = 7.7, Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 22.0 (Leu-CH3), 22.5 (Leu-CH3), 23.2 (acetyl-CH3), 24.5 
(Leu-CH), 28.2 (Boc-(CH3)3), 28.8 (Trp-CH2),  42.0 (Leu-CH2), 50.8 (Leu-α-CH), 52.1 (ester-
CH3), 53.4 (Trp-α-CH), 83.8 (Boc-C), 114.8 (Ar-C), 115.5 (Ar-C), 118.9 (Ar-C), 119.8 
(alkene-CH), 123.1 (Ar-C), 124.8 (Ar-C), 126.6 (Ar-C), 127.9 (Ar-C), 128.7 (Ar-C), 129.6 (Ar-
C), 132.0 (alkene-CH), 135.9 (Ar-C), 136.2 (Ar-C), 136.9 (Ar-C), 150.4 (C=O), 169.7 (C=O), 
170.3 (C=O), 171.9 (C=O). 
IR Umax /cm-1 (solid) 3282 m (N-H), 3058 w (C-H), 2955 w (C-H), 1728 s (ester C=O), 1637 m 
(amide C=O), 1325 m (C-H). 












Synthesis of modified peptide 5f 
 
Modified peptide 5f was prepared from Ac-Trp(Boc)-Met-OMe (4f) (0.117 g, 0.238 mmol) 
and styrene (0.109 mL, 0.952 mmol), using the general procedure in section 2.4. As judged 
by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-olefinated 
peptide 5f and a di-olefinated peptide in a ratio of 10:1. Purification by flash column 
chromatography (50% EtOAc/pet. ether) followed by recrystallisation from CH2Cl2 / hexanes 
gave 5f as an off-white solid (0.064 g, 45%); m.p. 100-103 °C, Rf 0.18 (50% EtOAc/pet. 
ether). 
1H NMR (400 MHz, CDCl3) δ 1.65 (9H, s, Boc-(CH3)3), 1.78-1.85 (1H, m, Met-CHH), 1.94-
2.01 (7H, m, Met-CHH / Met-CH3 / acetyl-CH3), 2.28-2.35 (2H, m, Met-CH2), 3.19 (1H, dd, J 
= 13.8, J = 9.8, Trp-CHH), 3.38 (1H, dd, J = 13.8, J = 5.5, Trp-CHH), 3.52 (3H, s, ester-CH3), 
4.40 (1H, m, Trp-α-CH), 4.79 (1H, m, Met-α-CH), 6.00 (1H, br d, J = 7.4, Trp-NH), 6.47 (1H, 
J = 7.4, Met-NH), 6.84 (1H, dd, J = 16.7, alkene-CH), 7.28-7.32 (3H, m, alkene-CH / Ar-H), 
7.35-7.40 (3H, m, Ar-H), 7.58-7.60 (2H, m, Ar-H), 7.69 (1H, d, J = 7.6, Ar-H), 8.12 (1H, d, J = 
8.2, Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 15.3 (Met-CH3), 23.2 (acetyl-CH3), 28.3 (Boc-(CH3)3), 28.8 
(Trp-CH2), 29.5 (Met-CH2), 31.9 (Met-CH2), 51.6 (Met-α-CH), 52.4 (ester-CH3), 53.5 (Trp-α-
CH), 83.9 (Boc-C), 114.8 (Ar-C), 115.6 (Ar-C), 118.8 (Ar-C), 119.7 (alkene-CH), 123.1 (Ar-
C), 124.8 (Ar-C), 126.6 (Ar-C), 127.9 (Ar-C), 128.7 (Ar-C), 129.6 (Ar-C), 132.0 (alkene-CH), 
136.0 (Ar-C), 136.1 (Ar-C), 136.9 (Ar-C), 150.4 (C=O), 169.7 (C=O), 170.6 (C=O), 170.9 
(C=O). 
IR Umax /cm-1 (solid) 3282 m (N-H), 3053 w (C-H), 2965 w (C-H), 1726 s (ester C=O), 1642 m 
(amide C=O), 1455 m (C-H), 1260 s (C-O).  













Synthesis of modified peptide 5g 
 
Modified peptide 5g was prepared from Ac-Gly-Leu-Trp(Boc)-OMe (4g) (0.126 g, 0.238 
mmol) and styrene (0.109 mL, 0.952 mmol), using the general procedure in section 2.4. As 
judged by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-
olefinated peptide 5g and a di-olefinated peptide in a ratio of 20:1. Purification by flash 
column chromatography (EtOAc) followed by recrystallisation from CH2Cl2 / hexanes gave 
5g as an off-white solid (0.102 g, 68%); m.p. 165-167 °C, Rf 0.20 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 0.84 (3H, d, J = 9.0, Leu-CH3), 0.86 (3H, d, J = 9.0, Leu-CH3), 
1.49-1.57 (3H, m, Leu-CH / Leu-CH2), 1.64 (9H, s, Boc-(CH3)3), 1.97 (3H, s, acetyl-CH3), 
3.32 (1H, dd, J = 14.4, J = 7.3, Trp-CHH), 3.39 (1H, dd, J = 14.4, J = 7.3, Trp-CHH), 3.59 
(3H, s, ester-CH3), 3.69-3.83 (2H, m, Gly-CH2), 4.34-4.39 (1H, m, Leu-α-CH), 4.88-4.93 (1H, 
m, Trp-α-CH), 6.31 (2H, br m, NH (x2)), 6.77 (1H, d, J = 16.6, alkene-CH), 7.15-7.23 (1H, m, 
Ar-H), 7.25-7.40 (6H, m, Ar-H / alkene-CH / NH), 7.56 (2H, d, J = 8.0, Ar-H), 8.11 (1H, d, J = 
8.0, Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 21.8 (Leu-CH3), 22.8 (Leu-CH3), 22.8 (acetyl-CH3), 24.6 
(Leu-CH), 27.6 (Trp-CH2), 28.3 (Boc-(CH3)3), 40.6 (Leu-CH2), 43.1 (Gly-CH2), 51.5 (Leu-α-
CH), 52.4 (ester-CH3), 52.5 (Trp-α-CH), 84.2 (Boc-C), 114.6 (Ar-C), 115.4 (Ar-C), 118.8 (Ar-
C), 119.9 (alkene-C), 122.9 (Ar-C), 124.7 (Ar-C), 126.6 (Ar-C), 128.1 (Ar-C), 128.8 (Ar-C), 
129.9 (Ar-C), 132.4 (alkene-C), 135.8 (Ar-C), 136.2 (Ar-C), 136.7 (Ar-C), 150.5 (C=O), 168.9 
(C=O), 170.9 (C=O), 171.4 (C=O), 172.1 (C=O). 
IR Umax /cm-1 (solid) 3273 m (N-H), 3060 w (C-H), 2958 w (C-H), 1730 s (ester C=O), 1631 m 
(amide C=O), 1541 m (C=C), 1224 s (C-O).  














Synthesis of modified peptide 5h 
 
Modified peptide 5h was prepared from Ac-Leu-Trp(Boc)-Leu-OMe (4h) (0.140 g, 0.238 
mmol) and styrene (0.109 mL, 0.952 mmol), using the general procedure in section 2.4. As 
judged by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-
olefinated peptide 5h and a di-olefinated peptide in a ratio of 12:1. Purification by flash 
column chromatography (50% EtOAc/pet. ether) followed by recrystallisation from CH2Cl2 / 
hexanes gave 5h as an off-white solid (0.113 g, 69%); m.p. 100-104 °C, Rf 0.24 (50% 
EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 0.81 (3H, t, J = 6.2, Leu-CH3), 0.83 (3H, t, J = 6.2, Leu-CH3),  
0.87 (3H, d, J = 6.2, Leu-CH3), 0.88 (3H, d, J = 6.2, Leu-CH3), 1.36-1.47 (4H, m, Leu-CHH 
(x2) / Leu-CH (x2)), 1.51-1.59 (2H, m, Leu-CHH (x2)),  1.64 (9H, s, Boc-(CH3)3), 1.91 (3H, s, 
acetyl-CH3), 3.27-3.37 (2H, m, Trp-CH2), 3.55 (3H, s, ester-CH3), 4.39-4.48 (2H, m, Leu-α-
CH / Trp-α-CH), 4.77 (1H, app q, J = 7.7, Leu-α-CH), 5.75 (1H, br d, J = 8.0, Leu-NH), 5.99 
(1H, br d, J = 8.0, Trp-NH), 6.73-6.77 (2H, m, alkene-CH / Leu-NH), 7.25-7.32 (3H, m, 
alkene-CH / Ar-H), 7.36 (1H, d, J = 7.4, Ar-H), 7.38-7.40 (2H, m, Ar-H), 7.58 (2H, d, J = 7.4, 
Ar-H), 7.71 (1H, br d, J = 7.4, Ar-H), 8.13 (1H, d, J = 7.8, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.0 (Leu-CH3), 22.0 (Leu-CH3), 22.6 (Leu-CH3), 22.8 
(Leu-CH3), 23.1 (acetyl-CH3), 24.6 (Leu-CH), 24.7 (Leu-CH), 28.0 (Trp-CH2), 28.2 (Boc-
(CH3)3), 41.3 (Leu-CH2), 41.6 (Leu-CH2), 50.8 (Leu-α-CH), 51.7 (Trp-α-CH), 52.2 (ester-
CH3), 53.3 (Leu-α-CH), 83.9 (Boc-C), 114.8 (Ar-C), 115.6 (Ar-C), 119.0 (alkene-C), 120.0 
(Ar-C), 123.1 (Ar-C), 124.8 (Ar-C), 126.7 (Ar-C), 128.0 (Ar-C),128.7 (Ar-C), 129.5 (Ar-C), 
132.2 (alkene-C), 135.9 (Ar-C), 136.3 (Ar-C), 136.8 (Ar-C), 150.4 (C=O), 169.9 (C=O), 170.0 
(C=O), 171.8 (C=O), 172.2 (C=O).   
IR Umax /cm-1 (solid) 3273 m (N-H), 3056 w (C-H), 2957 w (C-H), 1730 s (ester C=O), 1627 m 
(amide C=O), 1541 m (C=C).  















Synthesis of modified peptide 5i 
 
Modified peptide 5i was prepared from Ac-Met-Trp(Boc)-Met-OMe (4i) (0.148 g, 0.238 
mmol) and styrene (0.109 mL, 0.952 mmol), using the general procedure in section 2.4. As 
judged by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-
olefinated peptide 5i and the di-olefinated peptide in a ratio of 19:1. Purification by flash 
column chromatography (50% EtOAc/pet. ether) followed by recrystallisation from CH2Cl2 / 
hexanes gave 5i as an off-white solid (0.095 g, 55%); m.p. 144-146 °C, Rf 0.39 (50% 
EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.57 (9H, s, Boc-(CH3)3), 1.76-1.84 (2H, Met-CH2), 1.86 (3H, s, 
Met-CH3), 1.92 (3H, s, Met-CH3), 1.95-1.97 (4H, s, acetyl-CH3 / Met-CHH), 2.00-2.08 (1H, m, 
Met-CHH), 2.19-2.28 (2H, m, Met-CH2), 2.35-2.45 (2H, m, Met-CH2),  3.22 (1H, dd, J = 14.3, 
J = 8.6, Trp-CHH), 3.29 (1H, dd, J = 14.3, J = 6.8, Trp-CHH), 3.50 (3H, s, ester-CH3),  4.40 
(1H, dt, J = 7.3, J = 5.7, Met-α-CH), 4.50 (1H, app q, J = 7.8, Trp-α-CH), 4.69 (1H, app q, J = 
7.4, Met-α-CH), 6.18 (1H, d, J = 7.0, Met-NH), 6.20 (1H, d, J = 7.0, Met-NH), 6.71 (1H, d, J = 
16.8, alkene-CH), 6.91 (1H, br d, J = 7.8, Trp-NH), 7.16-7.33 (7H, m, alkene-CH / Ar-H), 
7.51 (2H, d, J = 7.4, Ar-H), 7.59 (1H, d, J = 7.4, Ar-H), 8.06 (1H, d, J = 7.4, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 15.1 (Met-CH3), 15.3 (Met-CH3), 23.1 (acetyl-CH3), 28.1 
(Trp-CH2), 28.2 (Boc-(CH3)3), 29.6 (Met-CH2), 30.0 (Met-CH2),  31.4 (Met-CH2), 31.6 (Met-
CH2), 51.7 (Met-α-CH), 52.3 (ester-CH3), 52.4 (Trp-α-CH), 53.6 (Met-α-CH), 84.0 (Boc-C), 
114.6 (Ar-C), 115.6 (Ar-C), 118.8 (Ar-C), 119.9 (alkene-C), 123.0 (Ar-C), 124.8 (Ar-C), 126.7 
(Ar-C), 128.0 (Ar-C), 128.7 (Ar-C), 129.5 (Ar-C), 132.3 (alkene-C), 136.0 (Ar-C), 136.3 (Ar-
C), 136.8 (Ar-C), 150.4 (C=O), 170.0 (C=O), 170.2 (C=O), 170.8 (C=O), 171.2 (C=O). 
IR Umax /cm-1 (solid) 3275 m (N-H), 3060w (C-H), 2920 w (C-H), 1728 s (ester C=O), 1634 m 
(amide C=O), 1453 m (C-H), 1258 s (C-O).  

















Synthesis of modified peptide 5j 
 
Modified peptide 5j was prepared from Ac-Trp(Boc)-Leu-Leu-OMe (4j) (0.140 g, 0.238 
mmol) and styrene (0.109 mL, 0.952 mmol), using the general procedure in section 2.4. As 
judged by 1H NMR spectroscopy, the crude residue contained a mixture of the mono-
olefinated peptide 5j and a di-olefinated peptide in a ratio of 11:1. Purification by flash 
column chromatography (50% EtOAc/pet. ether) followed by recrystallisation from CH2Cl2 / 
hexanes gave 5j as an off-white solid (0.097 g, 59%); m.p. 165-167 °C, Rf 0.26 (50% 
EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 0.74-0.80 (12H, Leu-CH3 (x4)), 1.24-1.50 (6H, m, Leu-CH2 (x2) 
/ Leu-CH (x2)), 1.58 (Boc-(CH3)3), 1.85 (acetyl-CH3), 3.21 (1H, dd, J = 14.3, J = 7.1, Trp-
CHH), 3.28 (1H, dd, J = 14.3, J = 7.1, Trp-CHH), 3.60 (3H, s, ester-CH3), 4.24 (1H, dt, J = 
8.1, J = 5.7, Leu-α-CH), 4.33-4.39 (1H, m, Leu-α-CH), 4.72 (1H, app q, J = 7.3, Trp-α-CH), 
6.12 (1H, br d, J = 8.1, Leu-NH), 6.20 (1H, br d, J = 7.9, Leu-NH), 6.25 (1H, br d, J = 7.3, 
Trp-NH), 6.69 (1H, d, J = 16.6, alkene-CH), 7.16-7.25 (4H, m, Ar-H), 7.28-7.35 (3H, m, 
alkene-CH / Ar-H), 7.49 (2H, d, J = 7.5, Ar-H), 7.64 (1H, br d, J = 7.5, Ar-H), 8.04 (1H, br d, J 
= 8.4, Ar-H).      
13C{1H} NMR (100 MHz, CDCl3) δ 21.0 (Leu-CH3), 21.0 (Leu-CH3), 21.6 (Leu-CH3), 21.7 
(Leu-CH3), 22.1 (acetyl-CH3), 23.5 (Leu-CH), 23.8 (Leu-CH), 27.3 (Boc-(CH3)3), 28.7 (Trp-
CH2), 40.0 (Leu-CH2), 40.3 (Leu-CH2), 49.8 (Trp-α-CH), 50.8 (Leu-α-CH), 51.2 (Leu-α-CH), 
52.6 (ester-CH3), 83.0 (Boc-C), 113.8 (Ar-C), 114.7 (Ar-C), 117.9 (Ar-C), 119.1 (alkene-C), 
122.0 (Ar-C), 123.9 (Ar-C), 125.6 (Ar-C), 127.0 (Ar-C), 127.8 (Ar-C), 128.6 (Ar-C), 131.3 
(alkene-C), 134.8 (Ar-C), 135.2 (Ar-C),135.8 (Ar-C), 149.4 (C=O), 169.2 (C=O), 169.7 
(C=O), 169.9 (C=O), 172.1 (C=O). 
IR Umax /cm-1 (solid) 3276 m (N-H), 2961 w (C-H), 1728 s (ester C=O), 1631 m (amide C=O), 
1541 m (C=C), 1455 m (C-H), 1258 s (C-O).  




















The salt L-tryptophan methyl ester hydrochloride (0.300 g, 1.178 mmol) was slurried in THF 
(15 mL) and cooled to 0 °C in an ice bath, before the addition of NEt3 (0.197 mL, 1.414 
mmol). Acetic anhydride (0.223 mL, 2.356 mmol) was then added, and the reaction mixture 
was stirred at 0 °C for 10 minutes before it was heated at 80 °C for 2 h. The resulting 
solution was allowed to cool to room temperature, before it was added to water (25 mL), and 
extracted with EtOAc (3 x 30 mL). The organic layers were combined and washed with 1M 
HCl (20 mL), sat. NaHCO3 solution (20 mL) and brine (20 mL). The organic layer was then 
dried (MgSO4), and reduced to a brown solid by rotary evaporation. The solid was then 
triturated (Et2O) and filtered to give SI-14 as a sandy brown solid (0.240 g, 78%), m.p. 154-
155 °C. 
1H NMR (400 MHz, CDCl3) δ 1.95 (3H, s, acetyl-CH3), 3.27-3.37 (2H, m, Trp-CH2), 3.70 (3H, 
s, ester-CH3), 4.95 (1H, dt, J = 7.8, J = 5.0, Trp-α-CH), 5.98 (1H, br d, J = 7.8, Trp-NH), 6.97 
(1H, d, J = 2.3, Trp-Ar-H), 7.10-7.13 (1H, m, Trp-Ar-H), 7.17-7.21 (1H, m, Ar-H), 7.36 (1H, d, 
J = 7.5, Trp-Ar-H), 7.52 (1H, d, J = 7.5, Trp-Ar-H) 8.14 (1H, m, Trp-Ar-NH).  
13C{1H} NMR (100 MHz, CDCl3) δ 23.3 (acetyl-CH3), 27.6 (Trp-CH2), 52.4 (ester-CH3), 53.0 
(Trp-α-CH), 110.1(Ar-C), 113.3 (Ar-C), 118.5 (Ar-C), 119.7 (Ar-C), 122.3 (Ar-C), 122.6 (Ar-
C), 127.7 (Ar-C), 136.0 (Ar-C), 169.7 (C=O), 172.4 (C=O).  














THF, 0 °C, 10 min






Ac-Trp-OMe (SI-14) (0.200 g, 0.768 mmol) was dissolved in CH2Cl2 (20 mL) and treated with 
NEt3 (0.129 mL, 0.922 mmol). A solution of Boc2O (0.335 g, 1.537 mmol) in CH2Cl2 (5 mL) 
was added dropwise to the solution, which was then heated under reflux for 16 h. The 
solution was then allowed to cool to room temperature, and concentrated by rotary 
evaporation. The crude compound was purified by flash column chromatography (50% 
EtOAc/pet. ether) to afforded 6 as a yellow solid (0.271 g, 98%); m.p. 57-59 °C, Rf 0.19 
(50% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.57 (Boc-(CH3)3), 1.88 (3H, s, acetyl-CH3), 3.10 (1H, dd, J = 
14.8, J = 5.5, Trp-CHH), 3.18 (1H, dd, J = 14.8, J = 5.5, Trp-CHH), 3.60 (3H, s, ester-CH3), 
4.84 (1H, dt, J = 7.7, J = 5.5, Trp-α-CH), 6.27 (1H, br d, J = 7.7, Trp-NH), 7.13 (1H, t, J = 7.7, 
Trp-Ar-H), 7.21 (1H, t, J = 7.7, Trp-Ar-H), 7.29 (1H, br s, Trp-Ar-H), 7.38 (1H, d, J = 7.7, Trp-
Ar-H), 8.01 (1H, br d, J = 6.3, Trp-Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.9 (acetyl-CH3), 27.1 (Trp-CH2), 28.0 (Boc-(CH3)3), 52.3 
(ester-CH3), 52.5 (Trp-α-CH), 83.6 (Boc-C), 114.8 (Ar-C), 115.1 (Ar-C), 118.6 (Ar-C), 122.4 
(Ar-C), 123.8 (Ar-C), 124.4 (Ar-C), 130.4 (Ar-C), 135.1 (Ar-C), 149.4 (C=O), 169.7 (C=O), 
172.0 (C=O). 
IR Umax /cm-1 (solid) 3286 m (N-H), 2978 w (C-H), 1727 s (ester C=O), 1654 m (amide C=O), 
1452 m (C-H), 1227 s (C-O).  

















CH2Cl2, 45 °C, 16 h
Boc
S52 
Synthesis of modified amino acid 7 
 
Modified amino acid 7 was prepared from Ac-Trp(Boc)-OMe (6) (0.058 g, 0.161 mmol) and 
styrene (0.074 mL, 0.644 mmol), using the general procedure in section 2.4. As judged by 
1H NMR spectroscopy, the crude residue contained a mixture of the mono-olefinated peptide 
7 and the starting material 6 only; there was no evidence of a di-olefinated product. 
Purification by flash column chromatography (50% EtOAc/pet. ether) followed by 
recrystallisation from CH2Cl2 / hexanes gave 7 as an off-white solid (0.029 g, 39%); m.p. 55-
56 °C, Rf 0.37 (50% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.64 (9H, s, Boc-(CH3)3), 1.88 (3H, s, acetyl-CH3), 3.38 (2H, d, 
J = 6.4, Trp-CH2), 3.51 (3H, s, ester-CH3), 4.93 (1H, dt, J = 7.6, J = 6.4, Trp-α-CH), 6.02 (1H, 
br d, J = 7.6, Trp-NH), 6.79 (1H, d, J = 16.6, alkene-CH), 7.23-7.33 (4H, m, Ar-H /alkene-
CH), 7.38 (2H, m, Ar-H), 7.55 (3H, m, Ar-H), 8.12 (1H, d, J = 8.4, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 23.1 (acetyl-CH3), 27.6 (Trp-CH2), 28.3 (Boc-(CH3)3), 52.4 
(ester-CH3), 52.5 (Trp-α-CH), 84.0 (Boc-C), 114.6 (Ar-C), 115.5 (Ar-C), 118.7 (Ar-C), 119.8 
(alkene-CH), 122.8 (Ar-C), 124.7 (Ar-C), 126.5 (Ar-C), 128.0 (Ar-C), 128.8 (Ar-C), 130.1 (Ar-
C), 132.4 (alkene-CH), 135.8 (Ar-C), 136.0 (Ar-C), 136.8 (Ar-C), 150.4 (C=O), 169.6 (C=O), 
172.4 (C=O). 
IR Umax /cm-1 (solid) 378 m (N-H), 2976 w (C-H), 1726 s (ester C=O), 1655 m (amide C=O), 
1359 m (C-H), 1206 s (C-O).  
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3.9. Control of residue selectivity in the C-H olefination of Trp / Phe peptides; 
synthesis of modified peptides 9-13 
3.9.1. Synthesis of peptides 8a, 8b, 8c 
Ac-Trp(Boc)-Phe-OMe (8a) 
 
Peptide 8a was synthesised from Ac-Trp-Phe-OMe (8b) (0.306 g, 0.75 mmol) using the 
general procedure described in section 2.3. Purification by flash column chromatography 
(75% EtOAc/pet. ether) followed by recrystallisation from CH2Cl2 / hexanes gave 8a as a 
white solid (0.381 g, 94%); m.p. 89-93 °C, Rf 0.25 (75% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.65 (9H, s, Boc-(CH3)3), 1.98 (3H, s, acetyl-CH3), 2.94 (1H, 
dd, J = 13.7, J = 6.0, Phe-CHH), 3.01-3.08 (2H, m, Phe-CHH/Trp-CHH), 3.20 (1H, dd, J = 
14.6, J = 5.5, Trp-CHH), 3.63 (3H, s, ester-CH3), 4.66-4.71 (2H, m, Ph-α-CH/Trp-α-CH), 6.09 
(1H, br d, J = 7.3, Trp-NH), 6.21 (1H, br d, J = 7.3, Phe-NH), 6.90-6.92 (2H, m, Phe-Ar-H), 
7.15-7.18 (3H, m, Phe-Ar-H), 7.22-7.26 (1H, m, Trp-Ar-H), 7.32 (1H, t, J = 8.2, Trp-Ar-H), 
7.45 (1H, s, Trp-Ar-H), 7.64 (1H, d, J = 7.8¸ Trp-Ar-H), 8.11-8.13 (1H, m, Trp-Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 23.2 (acetyl-CH3), 28.1 (Trp-CH2), 28.2 (Boc-(CH3)3), 37.8 
(Phe-CH2), 52.3 (ester-CH3), 53.3 (Trp-α-CH), 53.4 (Phe-α-CH), 83.6 (Boc-C), 115.2 (Ar-C), 
115.3 (Ar-C), 119.0 (Ar-C), 122.7 (Ar-C), 124.5 (Ar-C), 124.6 (Ar-C), 127.1 (Ar-C), 128.5 (Ar-
C), 129.1 (Ar-C), 130.1 (Ar-C), 135.3 (Ar-C), 135.4 (Ar-C), 149.5 (C=O), 169.9 (C=O), 170.3 
(C=O), 171.0 (C=O). 
IR Umax /cm-1 (solid) 3276 m (N-H), 3056 w (C-H), 2986 w (C-H), 1735 s (ester C=O), 1639 m 
(amide C=O), 1457 m (C-H), 1341 s (C-O).  














The peptide Ac-Trp-Phe-OMe (8b) was synthesised from N-acetyl-L-tryptophan (0.246 g, 
1.00 mmol) and L-phenylalanine methyl ester hydrochloride (0.539 g, 2.50 mmol) using the 
general procedure described in section 2.1. The crude compound was recrystallised from 
CH2Cl2 / hexanes to afford 8b as a cream solid (0.371 g, 91%); m.p. 73-76 °C. 
1H NMR (400 MHz, CDCl3) δ 1.96 (acetyl-CH3), 2.93 (1H, dd, J = 13.8, J = 7.8, Phe-CHH), 
2.97 (1H, dd, J = 13.8, J = 7.8, Phe-CHH), 3.10 (1H, dd, J = 14.1, J = 7.3, Trp-CHH), 3.27 
(1H, dd, J = 14.1, J = 5.0, Trp-CHH), 3.64 (3H, s, ester-CH3), 4.66-4.73 (2H, m, Trp-α-CH, 
Phe-α-CH), 6.08 (1H, br d, J = 7.3, Trp-NH), 6.26 (1H, br d, J = 7.8, Phe-NH), 6.85-6.87 (2H, 
m, Phe-Ar-H), 7.05 (1H, d, J = 2.3, Trp-Ar-H), 7.13-7.16 (5H, m, Phe-Ar-H / Trp-Ar-H), 7.35 
(1H, d, J = 7.6, Trp-Ar-H), 7.71 (1H, d, J = 8.4, Trp-Ar-NH), 8.11 (1H, br s, Trp-Ar-NH). 
13C{1H} NMR (100 MHz, CDCl3) δ 23.2 (acetyl-CH3), 28.2 (Trp-CH2), 37.7 (Phe-CH2), 52.2 
(ester-CH3), 53.3 (Phe-α-CH), 53.7 (Trp-α-CH), 110.3 (Ar-C), 111.2 (Ar-C), 118.7 (Ar-C), 
119.7 (Ar-C), 122.1 (Ar-C), 123.4 (Ar-C), 127.0 (Ar-C), 127.4 (Ar-C), 128.5 (Ar-C), 129.1 (Ar-
C), 135.5 (Ar-C), 136.1 (Ar-C), 170.0 (C=O), 170.9 (C=O), 171.3 (C=O). 
IR Umax /cm-1 (solid) 3291 m (O-H), 3064 w (C-H), 2969 w (C-H), 1737 s (ester C=O), 1637 m 
(amide C=O), 1541 m (C=C), 1445 m (C-H), 1216 s (C-O).  















Peptide Ac-Trp-Phe-OMe (8b) (0.200 g, 0.394 mmol) was dissolved in dry THF (10 mL) and 
cooled in a dry ice/acetone bath. NaHMDS (1M in THF, 0.394 mL, 0.394 mmol) was added 
dropwise at -78 °C and the reaction mixture was stirred for 1 h. Tri-iso-propylsilyl chloride 
(0.084 mL, 0.394 mmol) was added to the reaction mixture, which was then allowed to warm 
to room temperature overnight. The resulting solution was added to water (30 mL), extracted 
with EtOAc (4 x 30 mL), dried (MgSO4) and concentrated to a brown oil in vacuo. Following 
purification by flash column chromatography (50% EtOAc/pet. ether), peptide 8c was 
isolated as a yellow oil (0.162 g, 73%), Rf 0.31 (50% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.10 (18H, d, J = 7.3, TIPS-(CH3)2 (x3)), 1.86 (3H, septet, J = 
7.5, TIPS-CH (x3)),  1.89 (3H, s, acetyl-CH3), 2.95 (1H, dd, J = 13.7, J = 5.9, Phe-CHH), 
3.05 (1H, dd, J = 13.7, J = 5.9, Phe-CHH), 3.20 (2H, d, J = 6.9, Trp-CH2), 3.62 (3H, s, ester-
CH3), 4.67-4.78 (2H, m, Phe-α-CH / Trp-α-CH), 6.26 (1H, d, J = 7.3, Phe-NH), 6.47 (1H, d, J 
= 7.8, Trp-NH), 6.94-6.97 (2H, m, Phe-Ar-H), 7.08-7.13 (3H, m, Ar-H), 7.18-7.20 (3H, m, Ar-
H), 7.46 (1H, d, J = 8.2, Trp-Ar-H), 7.58 (1H, d, J = 8.2, Trp-Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 12.8 (TIPS-CH), 18.2 (TIPS-CH3), 23.2 (acetyl-CH3), 28.0 
(Trp-CH2), 37.9 (Phe-CH2), 52.3 (ester-CH3), 53.5 (α-CH), 53.6 (α-CH), 112.4 (Ar-C), 114.1 
(Ar-C), 118.7 (Ar-C), 119.9 (Ar-C), 121.7 (Ar-C), 127.2 (Ar-C), 128.6 (Ar-C), 129.3 (Ar-C), 
130.1 (Ar-C), 131.1 (Ar-C), 135.8 (Ar-C), 141.3 (Ar-C), 170.2 (C=O), 171.1 (C=O), 171.4 
(C=O). 
IR Umax /cm-1 (oil) 3280 m (N-H), 3062 w (C-H), 2946 w (C-H), 2866 w (C-H), 1746 s (ester 
C=O), 1638 m (amide C=O), 1541 m (C=C), 1452 m (C-H).  
















The dipeptide Fmoc-Trp(Boc)-Phe-OMe (SI-15) was synthesised from L-phenylalanine 
methyl ester hydrochloride (0.543 g, 2.50 mmol) and Fmoc-Trp(Boc)-OH (0.527 g, 1.00 
mmol), using the procedure in section 2.1. The crude compound was purified by flash 
column chromatography (25% EtOAc / pet ether) then recrystallised from CH2Cl2 / hexanes 
to afford SI-15 as a white solid (0.421 g, 61%); m.p. 100-103 °C, Rf 0.19 (25% EtOAc/pet. 
ether). 
1H NMR (400 MHz, CDCl3) δ 1.62 (9H, s, Boc-(CH3)3), 2.90-3.15 (3H, m, Trp-CHH/Phe-
CH2), 3.26 (1H, dd, J = 14.5, 4.1, Trp-CHH), 3.61 (3H, s, ester-CH3), 4.21 (1H, t, J = 6.8, 
Fmoc-CH), 4.31-4.44 (2H, m, Fmoc-CH2), 4.45-4.54 (1H, m, Trp-a-CH), 4.68-4.75 (1H, m, 
Phe-a-CH), 5.49 (1H, br d, J = 7.0, Trp-NH), 6.10 (1H, d, J = 7.4, Phe-NH), 6.86 (2H, br d, J 
= 7.0, Ar-H), 7.07-7.17 (3H, m, Ar-H), 7.23-7.35 (4H, m, Ar-H), 7.37-7.44 (2H, m, Ar-H), 7.47 
(1H, s, Ar-H), 7.51-7.56 (2H, m, Ar-H), 7.63 (1H, d, J = 7.3, Ar-H), 7.77 (2H, d, J = 7.6, Ar-H), 
8.14 (1H, br d, J = 7.1, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 28.1 (Boc-(CH3)3), 28.3 (Trp-CH2), 37.8 (Phe-CH2), 47.0 
(Fmoc-CH), 52.3 (ester-CH3), 53.3 (Phe-a-CH), 54.9 (Trp-a-CH), 67.3 (Fmoc-CH2), 83.7 
(Boc-C), 115.1 (Ar-C), 115.3 (Ar-C), 119.0 (Ar-C), 120.0 (Ar-C), 122.8 (Ar-C), 124.6 (Ar-C), 











































C), 130.1 (Ar-C), 135.3 (Ar-C), 135.5 (Ar-C), 141.3 (Ar-C), 143.7 (Ar-C), 149.4 (C=O), 155.8 
(C=O), 170.2 (C=O), 171.0 (C=O); 
IR Umax /cm-1 (solid) 3302 w (N-H), 3063 w (C-H), 2930 (C-H), 1727 m (ester C=O), 1675 s 
(Fmoc C=O), 1654 s (amide C=O), 1533 m (C=C), 1366 s (C-O), 1248 s (C-O); 
HRMS (ESI) [M+H+] m/z calcd. for C41H42N3O7: 688.3023, found: 688.3006. 
H-Trp(Boc)-Phe-OMe (SI-16) 
 
Fmoc-Trp(Boc)-Phe-OMe (SI-15) (0.421 g, 0.612 mmol) was dissolved in CH2Cl2 (20 mL) 
and treated with tris(2-aminoethyl)amine (0.914 mL, 6.120 mmol). The reaction mixture was 
stirred for 2 h before being quenched with H2O (20 mL). The organic layer was then washed 
with 1 M HCl (20 mL), sat. NaHCO3 (20 mL) and H2O (20 mL), dried (MgSO4) and the 
solvent removed in vacuo to yield an off-white solid. Purification by flash column 
chromatography (EtOAc) followed by recrystallisation from CH2Cl2 / hexanes yielded SI-16 
as a white solid (0.223 g, 78%); m.p. 81-83 °C, Rf 0.22 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.38 (2H, br s, NH2), 1.65 (9H, s, Boc-(CH3)3), 2.76 (1H, dd, J = 
14.4, 8.9, Trp-CHH), 3.04 (2H, d, J = 6.1, Phe-CH2), 3.22 (1H, dd, J = 14.4, 3.7, Trp-CHH), 
3.66-3.73 (4H, m, ester-CH3/Trp-a-CH), 4.88 (1H, dt, J = 8.4, 6.1, Phe-a-CH), 6.94-6.99 (2H, 
m, Ar-H), 7.17-7.28 (4H, m Ar-H), 7.33 (1H, t, J = Ar-H), 7.46 (1H, s, Ar-H), 7.61 (1H, d, J = 
7.7, Ar-H), 7.77 (1H, d, J = 8.2, Phe-NH), 8.13 (1H, br d, J = 8.2, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 28.1 (Boc-(CH3), 30.3 (Trp-CH2), 37.9 (Phe-CH2), 52.2 
(Phe-a-CH), 52.6 (Trp-a-CH), 54.6 (ester-CH3), 83.6 (Boc-C), 115.2 (Ar-C), 116.4 (Ar-C), 
119.2 (Ar-C), 122.6 (Ar-C), 124.1 (Ar-C), 124.6 (Ar-C), 126.9 (Ar-C), 128.3 (Ar-C), 129.1 (Ar-
C), 130.2 (Ar-C), 135.5 (Ar-C), 135.8 (Ar-C), 149.5 (C=O), 171.8 (C=O), 173.9 (C=O). 
IR Umax /cm-1 (solid) 3353 w (N-H), 3029 w (C-H), 2930 w (C-H), 1728 s (ester C=O), 1664 s 
(amide C=O), 1496 (C=C), 1252 (C-O). 













The dipeptide H-Trp(Boc)-Phe-OMe (SI-16) (0.365 g, 0.784 mmol) was dissolved in CH2Cl2 
(30 mL), treated with N-acetyl-glycine (0.037 g, 0.314 mmol), DIPEA (0.055 mL, 0.314 
mmol), HBTU (0.119 g, 0.314 mmol) and stirred for 16 h at room temperature. The reaction 
mixture was diluted with CH2Cl2 (30 mL) and washed with 1M HCl (20 mL), sat. NaHCO3 
solution (3 x 20 mL) and water (20 mL). The solution was dried (MgSO4) and then 
concentrated in vacuo. The crude compound was purified by flash column chromatography 
(EtOAc) and then recrystallised from CH2Cl2 / hexanes to afford peptide SI-17 as a white 
solid (0.134 g, 76%); m.p. 186-188 °C, Rf 0.19 (EtOAc). 
1H NMR (400 MHz, CD3CN) δ 1.64 (9H, s, Boc-(CH3)3), 1.86 (3H, s, acetyl-CH3), 2.90-3.01 
(2H, m, Phe-CHH / Trp-CHH), 3.05 (1H, dd, J = 13.8, 5.8, Trp-CHH), 3.14 (1H, dd, J = 14.9, 
5.5, Phe-CHH), 3.61 (3H, s, ester-CH3), 3.65 (2H, dd, J = 5.6, 3.5, Gly-CH2), 4.54-4.65 (2H, 
m, Phe-a-CH / Trp-a-CH), 6.70 (1H, br t, J = 5.3, Gly-NH), 6.87 (1H, d, J = 8.0, Phe-NH), 
7.03 (1H, d, J = 7.6, Trp-NH), 7.10-7.17 (2H, m, Ar-H), 7.20-7.35 (5H, m, Ar-H), 7.47 (1H, s, 
Ar-H), 7.59 (1H, d, J = 7.6, Ar-H), 8.09 (1H, d, J = 8.2, Ar-H). 
13C{1H} NMR (100 MHz, D6-DMSO) δ 22.4 (acetyl-CH3), 27.4 (Phe-CH2), 27.7 (Boc-(CH3)3), 
36.6 (Trp-CH2), 41.9 (Gly-CH2), 51.8 (ester-CH3), 52.1 (Phe-a-CH), 53.7 (Trp-a-CH), 83.5 
(Boc-C), 114.6 (Ar-C), 116.2 (Ar-C), 119.4 (Ar-C), 122.4 (Ar-C), 124.1 (Ar-C), 124.3 (Ar-C), 
126.6 (Ar-C), 128.3 (Ar-C), 129.1 (Ar-C), 130.3 (Ar-C), 134.6 (Ar-C), 137.0 (Ar-C), 149.1 
(C=O), 168.8 (C=O), 169.5 (C=O), 171.1 (C=O), 171.7 (C=O). 
IR Umax /cm-1 (solid) 3302 m (N-H), 3066 w (C-H), 2982 w (C-H), 1731 s (ester C=O), 1634 s 
(amide C=O), 1519 s (C=C), 1209 s (C-O). 















3.9.3. C-H olefination of Ac-Trp(Boc)-Phe-OMe (8a); synthesis of modified 
peptides 9a-e 
 
C-H olefination of Ac-Trp(Boc)-Phe-OMe (8a) (0.100 g, 0.197 mmol) with styrene (0.087 mL, 
0.788 mmol) was carried out as described by the general procedure in section 2.4. The 
crude residue was purified by column chromatography followed by recrystallization from 
CH2Cl2 / hexanes to afford the following modified peptides, all as off-white solids: 
9a (0.048 g, 22%); m.p. 152-153 °C, Rf 0.29 (50% EtOAc/pet. ether)  
9b (0.035 g, 16%); m.p. 117-118 °C, Rf 0.22 (50% EtOAc/pet. ether) 
9c (0.033 g, 13%); m.p. 100-102 °C, Rf 0.45 (50% EtOAc/pet. ether) 
9d (0.018 g, 7%); m.p. 120-122 °C, Rf 0.39 (50% EtOAc/pet. ether) 
9e (0.018 g, 6%); m.p.106-108 °C, Rf 0.61 (50% EtOAc/pet. ether). 
Data for 9a: 
1H NMR (400 MHz, CDCl3) δ 1.55 (9H, s, Boc-(CH3)3), 1.90 (3H, s, acetyl-CH3), 2.79 (1H, 
dd, J = 13.8, J = 6.0, Phe-CHH), 2.90 (1H, dd, J = 13.8, J = 6.0, Phe-CHH), 3.12 (1H, dd, J = 
14.1, J = 9.7, Trp-CHH), 3.25 (1H, dd, J = 14.0, J = 5.6, Trp-CHH), 3.37 (3H, s, ester-CH3), 
4.45-4.50 (1H, m, Trp-α-CH), 4.63-4.68 (1H, m, Phe-α-CH), 5.87 (1H, br d, J = 7.8, Trp-NH), 
6.42 (1H, br d, J = 7.4, Phe-NH), 6.75 (1H, d, J = 16.7, alkene-CH), 6.83-6.85 (2H, m, Ar-H), 
7.08-7.10 (2H, m, Ar-H), 7.16-7.22 (4H, m, Ar-H), 7.28-7.31 (3H, m, Ar-H), 7.48-7.58 (3H, m, 
Ar-H), 8.02 (1H, br d, J = 8.2, Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 23.1 (acetyl-CH3), 28.2 (Boc-(CH3)3), 28.6 (Trp-CH2),  38.1 
(Phe-CH2), 52.1 (ester-CH3), 53.5 (α-CH), 53.5 (α-CH), 83.9 (Boc-C), 114.9 (Ar-C), 115.4 
(Ar-C), 118.8 (Ar-C), 119.7 (alkene-C), 123.0 (Ar-C), 124.7 (Ar-C), 126.6 (alkene-C), 127.0 
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9c, 13% 9d, 7%
9a, 22%8a
S60 
C), 135.4 (Ar-C), 135.9 (Ar-C), 136.0 (Ar-C), 136.9 (Ar-C), 150.4 (C=O), 169.7 (C=O), 170.4 
(C=O), 170.4 (C=O).  
IR Umax /cm-1 (solid) 3282 m (N-H), 3060 w (C-H), 2963 w (C-H), 1726 s (ester C=O), 1642 m 
(amide C=O), 1522 m (C=C), 1258 s (C-O).  
HRMS (ESI) [M+H+] m/z calcd. for C36H40N3O6: 610.2912, found: 610.2912. 
Data for 9b: 
1H NMR (400 MHz, CDCl3) δ 1.56 (9H, s, Boc-(CH3)3), 1.74 (3H, s, acetyl-CH3), 2.94 (1H, 
dd, J = 14.4, J = 8.2, Phe-CHH), 2.98-3.09 (2H, m, Phe-CHH / Trp-CHH), 3.20 (1H, dd, J = 
14.0, J = 6.4, Trp-CHH), 3.47 (3H, s, ester-CH3), 4.52-4.60 (2H, m, Phe-α-CH / Trp-α-CH), 
6.14-6.20 (2H, m, Phe-NH / Trp-NH), 6.79 (1H, d, J = 7.6, Ar-H), 6.87 (1H, d, J = 16.1, 
alkene-CH), 7.00 (1H, t, J = 7.3, Ar-H), 7.13 (2H, app q, J = 7.6, Ar-H), 7.19-7.23 (3H, m, Ar-
H / alkene-CH), 7.26-7.32 (3H, m, Ar-H), 7.45-7.52 (4H, m, Ar-H), 8.02 (1H, m, Ar-H).   
13C{1H} NMR (100 MHz, CDCl3) δ 22.9 (acetyl-CH3), 28.1 (Trp-CH2), 28.1 (Boc-(CH3)3), 35.0 
(Phe-CH2), 52.3 (ester-CH3), 53.2 (α-CH), 53.3 (α-CH), 83.5 (Boc-C), 115.1 (Ar-C), 115.2 
(Ar-C), 119.0 (Ar-C), 122.6 (Ar-C), 124.4 (Ar-C), 124.5 (Ar-C), 125.1 (Ar-C), 125.7 (alkene-
C), 126.5 (Ar-C), 126.6 (Ar-C), 127.5 (Ar-C), 127.6 (Ar-C), 127.8 (Ar-C), 128.7 (Ar-C), 130.1 
(Ar-C), 130.4 (Ar-C), 130.5 (Ar-C), 133.3 (alkene-C), 136.5 (Ar-C), 137.2 (Ar-C), 149.4 
(C=O), 169.9 (C=O), 170.4 (C=O), 171.1 (C=O).  
IR Umax /cm-1 (solid) 3280 m (N-H), 2963 w (C-H), 1731 s (ester C=O), 1638 m (amide C=O), 
1452 m (C-H), 1258 s (C-O).  
HRMS (ESI) [M+H+] m/z calcd. for C36H40N3O6: 610.2912, found: 610.2912. 
Data for 9c: 
1H NMR (400 MHz, CDCl3) δ 1.62 (9H, s, Boc-(CH3)3), 1.77 (3H, s, acetyl-CH3), 3.04 (1H, 
dd, J = 14.2, J = 5.2, Phe-CHH), 3.11 (1H, dd, J = 14.0, J = 10.0, Trp-CHH), 3.23 (1H, dd, J 
= 14.2, J = 7.2, Phe-CHH), 3.32-3.41 (1H, m, Trp-CHH), 3.38 (3H, s, ester-CH3), 4.48-4.52 
(1H, m, Trp-α-CH), 4.61-4.67 (1H, m, Phe-α-CH), 5.82 (1H, br d, J = 7.2, Trp-NH), 6.33 (1H, 
br d, J = 7.2, Phe-NH), 6.61-6.85 (2H, m, alkene-CH / Ar-H), 6.98 (1H, d, J = 16.0, alkene-
CH), 7.17-7.40 (13H, m, Ar-H / alkene-CH), 7.55-7.63 (5H, m, Ar-H), 8.08 (1H, d, J = 8.4, Ar-
H).  
13C{1H} NMR (100 MHz, CDCl3) δ 22.9 (acetyl-CH3), 28.2 (Boc-(CH3)3), 28.8 (Trp-CH2),  35.2 
(Phe-CH2), 52.2 (ester-CH3), 53.5 (α-CH),  53.5 (α-CH), 83.8 (Boc-C), 115.0 (Ar-C), 115.4 
(Ar-C), 118.8 (Ar-C), 119.6 (alkene-C), 123.0 (Ar-C), 124.7 (Ar-C), 125.2 (Ar-C), 125.6 (Ar-
C), 126.6 (Ar-C), 126.7 (Ar-C), 127.4 (Ar-C), 127.5 (Ar-C), 127.7 (Ar-C), 127.8 (Ar-C), 128.7 
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(Ar-C), 130.3 (Ar-C), 130.4 (Ar-C), 131.9 (Ar-C), 133.3 (alkene-C), 135.9 (Ar-C), 135.9 (Ar-
C), 136.6 (Ar-C), 136.9 (Ar-C), 137.4 (Ar-C), 150.4 (C=O), 169.6 (C=O), 170.3 (C=O), 170.5 
(C=O).   
IR Umax /cm-1 (solid) 3282 m (N-H), 2976 w (C-H), 1726 s (ester C=O), 1645 m (amide C=O), 
1541 m (C=C), 1233 s (C-O).  
HRMS (ESI) [M+H+] m/z calcd. for C44H46N3O6: 712.3381, found: 712.3382. 
Data for 9d: 
1H NMR (400 MHz, CDCl3) δ 1.62 (9H, s, Boc-(CH3)3), 1.80 (3H, s, acetyl-CH3), 2.96 (1H, 
dd, J = 14.5, J = 8.2, Trp-CHH), 3.12 (1H, dd, J = 14.5, J = 8.2, Trp-CHH), 3.34-3.37 (2H, m, 
Phe-CH2), 3.41 (3H, s, ester-CH3), 4.57-4.68 (2H, m, Trp-α-CH / Phe-α-CH), 6.12 (1H, br d, 
J = 7.3, Trp-NH), 6.17 (1H, br d, J = 7.7, Phe-NH), 6.96 (2H, d, J = 16.0, alkene-CH), 7.12 
(1H, t, J = 7.4, Ar-H), 7.23-7.31 (4H, m, Ar-H / alkene-CH), 7.33-7.42 (6H, m, Ar-H /alkene-
CH), 7.50-7.57 (8H, m, Ar-H), 8.08 (1H, d, J = 8.1, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 23.1 (acetyl-CH3), 28.3 (Boc-(CH3)3), 28.4 (Trp-CH2),  31.6 
(Phe-CH2), 52.7 (Phe-α-CH), 53.1 (ester-CH3), 53.5 (Trp-α-CH), 83.7 (Boc-C), 115.3 (Ar-C), 
119.1 (Ar-C), 119.7 (Ar-C), 122.8 (Ar-C), 123.1 (Ar-C), 124.6 (Ar-C), 125.7 (Ar-C), 126.1 
(alkene-C), 126.9 (Ar-C), 127.7 (Ar-C), 128.0 (Ar-C), 128.9 (Ar-C), 130.3 (Ar-C), 130.4 (Ar-
C), 131.7 (alkene-C), 132.1 (Ar-C), 137.3 (Ar-C), 137.9 (Ar-C), 149.6 (C=O), 169.9 (C=O), 
170.4 (C=O), 171.3 (C=O).  
IR Umax /cm-1 (solid) 3282 m (N-H), 3055 w (C-H), 2965 w (C-H), 1728 s (ester C=O), 1638 m 
(amide C=O), 1451 m (C-H), 1258 s (C-O).  
HRMS (ESI) [M+H+] m/z calcd. for C44H46N3O6: 712.3381, found: 712.3375. 
Data for 9e: 
1H NMR (400 MHz, CDCl3) δ 1.60 (9H, s, Boc-(CH3)3), 1.82 (3H, s, acetyl-CH3), 3.10 (1H, 
dd, J = 13.8, J = 10.0, Trp-CHH), 3.21 (3H, s, ester-CH3), 3.26-3.44 (3H, m, Trp-CHH / Phe-
CH2), 4.55 (1H, dt, J = 7.8, J = 6.4, Trp-α-CH), 4.65-4.71 (1H, m, Phe-α-CH), 5.90 (1H, br d, 
J = 7.8, Trp-NH), 6.36 (1H, br d, J = 7.3, Phe-NH), 6.81 (1H, d, J = 16.7, Trp-alkene-CH), 
6.95 (2H, d, J = 16.0, Phe-alkene-CH), 7.10 (2H, t, J = 7.8, Ar-H), 7.20-7.31 (7H, m, Ar-H / 
alkene-CH), 7.36-7.41 (7H, m, Ar-H / alkene-CH), 7.50-7.61 (8H, m, Ar-H), 8.05 (1H, d, J = 
7.8, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 23.1 (acetyl-CH3), 28.4 (Boc-(CH3)3), 29.8 (Trp-CH2), 31.9 
(Phe-CH2), 52.6 (ester-CH3), 53.1 (α-CH), 53.8 (α-CH), 84.0 (Boc-C), 115.1 (Ar-C), 115.4 
(Ar-C), 118.9 (alkene-C), 119.7 (Ar-C), 123.1 (Ar-C), 123.2 (Ar-C), 124.8 (Ar-C), 125.6 (Ar-
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C), 126.1 (alkene-C), 126.8 (Ar-C), 126.9 (Ar-C), 127.5 (Ar-C), 127.9 (Ar-C), 128.8 (Ar-C), 
128.9 (Ar-C), 128.9 (Ar-C), 129.6 (Ar-C), 131.4 (alkene-C), 131.8 (alkene-C), 136.0 (Ar-C), 
137.5 (Ar-C), 137.9 (Ar-C), 150.4 (C=O), 169.7 (C=O), 170.3 (C=O), 170.6 (C=O). There are 
two Ar-C signals missing; presumably these overlap with other signals in the spectrum. 
IR Umax /cm-1 (solid) 3308 m (N-H), 3026 w (C-H), 2963 w (C-H), 1726 s (ester C=O), 1655 m 
(amide C=O), 1508 m (C=C), 1450 m (C-H), 1237 s (C-O).  
HRMS (ESI) [M+H+] m/z calcd. for C52H52N3O6: 814.3851, found: 814.3852. 
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3.9.4. C-H olefination of Ac-Gly-Trp(Boc)-Phe-OMe (SI-17); synthesis of 
modified peptides SI-18a, SI-18b and SI-18c 
 
C-H olefination of Ac-Gly-Trp(Boc)-Phe-OMe (SI-17) (0.134 g, 0.237 mmol) with styrene 
(0.109 mL, 0.952 mmol) was carried out as described in the general procedure in section 
2.4. The crude residue was purified by flash column chromatography (EtOAc) followed by 
recrystallization from CH2Cl2 / hexanes to afford the following modified peptides, all as yellow 
solids. 
SI-18a (0.040 g, 25%); m.p. 104-106 °C, Rf 0.25 (EtOAc). 
SI-18b (0.029 g, 16%); m.p. 119-122 °C, Rf 0.30 (EtOAc). 
SI-18c (0.005 g, 2%); m.p. 159-161 °C, Rf 0.43 (EtOAc). 
Data for SI-18a: 
1H NMR (400 MHz, CDCl3) δ 1.62 (9H, s, Boc-(CH3)3), 1.97 (3H, s, acetyl-CH3), 2.89 (1H, 
dd, J = 13.7, 5.9, Trp-CHH), 2.98 (1H, dd, J = 13.7, 6.0, Trp-CHH), 3.25 (1H, dd, J = 14.1, 
8.9, Phe-CHH), 3.33 (1H, dd, J = 14.1, 6.3, Phe-CHH), 3.50 (3H, s, ester-CH3), 3.84-3.88 
(2H, m, Gly-CH2), 4.55-4.62 (1H, m, Trp-a-CH), 4.71-4.78 (1H, m, Phe-a-CH), 6.06-6.16 
(2H, m, Trp-NH / Gly-NH), 6.74 (1H, d, J = 7.6, Phe-NH), 6.78 (1H, d, J = 16.7, alkene-CH), 
6.89-6.93 (1H, m, Ar-H), 7.13-7.17 (2H, m, Ar-H), 7.19-7.32 (5H, m, Ar-H / alkene-CH), 7.33-
7.40 (3H, m, Ar-H), 7.51-7.58 (2H, m, Ar-H), 7.62 (1H, d, J = 7.6, Ar-H), 8.10 (1H, d, J = 8.2, 
Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.9 (acetyl-CH3), 28.2 (Boc-(CH3)3), 28.8 (Phe-CH2), 38.0 


























































Pd(OAc)2 (10 mol %)
AgOAc (2.5 eq), air
PhMe (0.08 M)
100 °C, 2 h
SI-17 SI-18a, 25% SI-18b, 16%
SI-18c, 2%
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C), 114.6 (Ar-C), 115.6 (Ar-C), 118.7 (Ar-C), 119.8 (alkene-C), 123.0 (Ar-C), 124.8 (Ar-C), 
126.6 (Ar-C), 127.0 (Ar-C), 128.0 (Ar-C), 128.4 (Ar-C), 128.7 (Ar-C), 129.1 (Ar-C), 129.6 (Ar-
C), 132.2 (alkene-C), 135.4 (Ar-C), 135.9 (Ar-C), 136.2 (Ar-C), 136.8 (Ar-C), 150.4 (C=O), 
168.4 (C=O), 169.8 (C=O), 170.4 (C=O), 170.7 (C=O). 
IR Umax /cm-1 (solid) 3278 m (N-H), 3060 w (C-H), 2968 w (C-H), 1725 s (ester C=O), 1636 s 
(amide C=O), 1522 s (C=C), 1210 s (C-O). 
HRMS (ESI) [M+H+] m/z calcd. For C38H43N4O7: 667.3132, found: 667.3127. 
Data for SI-18b: 
1H NMR (400 MHz, CDCl3) δ 1.61 (9H, s, Boc-(CH3)3), 1.96 (3H, s, acetyl-CH3), 3.05 (1H, 
dd, J = 14.2, 5.3 Trp-CHH), 3.16 (1H, dd, J = 14.1, 9.4, Phe-CHH), 3.24 (1H, dd, J = 14.2, 
7.0, Trp-CHH), 3.31 (1H, dd, J = 14.1, 5.8, Phe-CHH), 3.43 (3H, s, ester-CH3), 3.60 (1H, dd, 
J = 16.8, 5.0, Gly-CHH), 3.69 (1H, dd, J = 16.8, 5.0, Gly-CHH), 4.50-4.58 (1H, m, Trp-a-CH), 
4.62 (1H, m, Phe-a-CH), 5.90-5.99 (2H, m, Gly-NH / Trp-NH), 6.60 (1H, d, J = 7.3, Phe-NH), 
6.76 (1H, d, J = 16.6, Trp-alkene-CH), 6.83 (1H, d, J = 7.4, Ar-H), 6.94 (1H, d, J = 16.0, Phe-
alkene-CH), 7.06 (1H, t, J = 7.3, Ar-H), 7.10-7.22 (2H, m, Ar-H), 7.23-7.30 (3H, m, Ar-H), 
7.31-7.41 (6H, m, Ar-H / Phe-alkene-CH / Trp-alkene-CH), 7.50-7.60 (6H, m, Ar-H), 8.09 
(1H, d, J = 8.0, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.9 (acetyl-CH3), 28.2 (Boc-(CH3)3), 28.5 (Phe-CH2), 35.1 
(Trp-CH2), 42.7 (Gly-CH2), 52.3 (ester-CH3), 53.4 (Phe-α-CH), 53.5 (Trp-α-CH), 83.9 (Boc-
C), 114.6 (Ar-C), 115.5 (Ar-C), 118.7 (Ar-C), 119.7 (Trp-alkene-C), 123.0 (Ar-C), 124.8 (Ar-
C), 125.3 (Ar-C), 125.7 (Ar-C), 126.6 (Ar-C) 126.7 (Ar-C), 127.5 (Ar-C), 127.5 (Ar-C), 127.8 
(Ar-C), 127.9 (Ar-C), 128.7 (Ar-C), 128.8 (Phe-alkene-C), 129.6 (Ar-C), 130.2 (Phe-alkene-
C), 130.4 (Ar-C), 132.1 (Trp-alkene-C), 133.4 (Ar-C), 135.9 (Ar-C), 136.1 (Ar-C), 136.6 (Ar-
C), 136.8 (Ar-C), 137.4 (Ar-C), 150.4 (C=O), 168.1 (C=O), 169.8 (C=O), 170.2 (C=O), 170.6 
(C=O). 
IR Umax /cm-1 (solid) 3273 w (N-H), 3056 w (C-H), 2976 w (C-H), 1728 s (ester C=O), 1634 s 
(amide C=O), 1523 s (C=C), 1216 s (C-O). 
HRMS (ESI) [M+H+] m/z calcd. For C46H49N4O7: 769.3601, found: 769.3625. 
Data for SI-18c: 
1H NMR (400 MHz, CDCl3) δ 1.60 (9H, s, Boc-(CH3)3), 1.98, (3H, s, acetyl-CH3), 3.14 (1H, 
dd, J = 13.8, 9.8, Phe-CHH), 3.25 (3H, s, ester-CH3), 3.26-3.40 (3H, m, Phe-CHH / Trp-CH2), 
3.64 (1H, dd, J = 16.7, 5.0, Gly-CHH), 3.71 (1H, dd, J = 16.7, 5.0, Gly-CHH), 4.54-4.62 (1H, 
m, Trp-a-CH), 4.63-4.70 (1H, m, Phe-a-CH), 5.90 (1H, t, J = 5.9, Gly-NH), 5.96 (1H, d, J = 
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7.4, Trp-NH), 6.54 (1H, d, J = 6.6, Phe-NH), 6.74 (1H, d, J = 16.7, Trp-alkene-CH), 6.93 (2H, 
d, J = 16.0, Phe-alkene-CH), 7.07-715 (1H, m, Ar-H), 7.20-7.33 (9H, m, Ar-H / Trp-alkene-
CH), 7.34-7.42 (6H, m, Ar-H / Phe-alkene-CH), 7.47-7.60 (8H, m, Ar-H), 8.07 (1H, d, J = 8.1, 
Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 23.0 (acetyl-CH3), 28.2 (Boc-(CH3)3), 29.7 (Phe-CH2), 31.7 
(Trp-CH2), 42.8 (Gly-CH2), 52.5 (ester-CH3), 53.0 (Phe-α-CH), 53.5 (Trp-α-CH), 83.9 (Boc-
C), 114.6 (Ar-C), 115.5 (Ar-C), 118.7 (Ar-C), 119.6 (Trp-alkene-C), 123.1 (Ar-C), 124.8 (Ar-
C), 125.5 (Ar-C), 126.1 (Ar-C), 126.6 (Ar-C), 126.8 (Ar-C), 127.5 (Ar-C), 127.9 (Ar-C), 128.5 
(Ar-C), 128.7 (Ar-C), 128.8 (Phe-alkene-C), 129.6 (Ar-C), 131.3 (Phe-alkene-C), 131.4 (Ar-
C), 132.0 (Trp-alkene-C), 135.9 (Ar-C), 136.2 (Ar-C), 136.8 (Ar-C), 137.3 (Ar-C), 137.7 (Ar-
C), 150.4 (C=O), 168.0 (C=O), 169.6 (C=O), 170.2 (C=O), 170.7 (C=O); 
IR Umax /cm-1 (solid) 3304 m (N-H), 3058 w (C-H), 2980 w (C-H), 1731 s (ester C=O), 1634 s 
(amide C=O), 1519 s (C=C), 1215 s (C-O). 




3.9.5. C-H olefination of Ac-Trp-Phe-OMe (8b); synthesis of modified 
peptide 10 
 
Modified peptide 11 was prepared from Ac-Trp-Phe-OMe (8b) (0.146 g, 0.359 mmol), 
Pd(OAc)2 (8 mg, 0.036 mmol, 10 mol%), AgOAc (0.150 g, 0.898 mmol) and styrene (0.165 
mL, 1.436 mmol) were stirred together in toluene (4 mL) at 130 °C for 12 h.  Purification by 
flash column chromatography (EtOAc) followed by recrystallisation from CH2Cl2 / hexanes 
gave 10 as a brown solid (0.039 g, 21%); m.p. 171-173 °C, Rf 0.25 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.98 (3H, s, Acetyl-CH3), 2.82 (1H, dd, J = 13.5, 5.5, Trp-CHH), 
2.92 (1H, dd, J = 14.0, 5.7, Trp-CHH), 3.17 (1H, dd, J = 14.2, 9.5, Phe-CHH), 3.45-3.55 (4H, 
m, Phe-CHH / Ester-CH3), 4.51-4.58 (1H, m, Trp-α-CH), 4.62-4.69 (1H, m, Phe-α-CH), 6.01 
(1H, d, J = 6.9, Trp-NH), 6.43 (1H, d, J = 7.3, Phe-NH), 6.75-6.80 (2H, m, Ar-H), 6.84 (1H, d, 
J = 16.5, Alkene-CH), 7.02-7.38 (10H, m, Alkene-CH / Ar-H), 7.54 (2H, d, J = 7.6, Ar-H), 
7.61 (1H, d, J = 7.8, Ar-H), 8.52 (1H, s, Trp-Ar-NH).   
13C{1H} NMR (100 MHz, CDCl3) δ 23.3 (Acetyl-CH3), 27.6 (Phe-CH2), 37.9 (Trp-CH2), 52.1 
(Ester-CH3), 53.6 (Trp-α-CH), 54.5 (Phe-α-CH), 110.6 (Ar-C), 110.9 (Ar-C), 116.5 (Alkene-
CH), 118.8 (Ar-C), 120.1 (Ar-C), 123.3 (Ar-C), 126.4 (Ar-C), 126.9 (Ar-C), 127.1 (Alkene-
CH), 127.8 (Ar-C), 128.3 (Ar-C), 128.6 (Ar-C), 128.8 (Ar-C), 128.9 (Ar-C), 129.1 (Ar-C), 
129.2 (Ar-C), 134.0 (Ar-C), 135.4 (Ar-C), 136.5 (Ar-C), 136.7 (Ar-C), 169.9 (C=O), 170.5 
(C=O), 170.7 (C=O).   
IR Umax /cm-1 (solid) 3424 w (N-H), 3282 m (N-H), 3030 w (C-H), 2924 w (C-H), 1730 s (Ester 
C=O), 1636 (Amide C=O), 1541 s (C=C), 1218 s (C-O). 



























Pd(OAc)2 (10 mol %)
AgOAc (2.5 eq), air
PhMe (0.08 M)
100 °C, 2 h
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3.9.6. C-H olefination of Ac-Trp(TIPS)-Phe-OMe (8c); synthesis of modified 
peptide 11 
 
Ac-Trp(TIPS)-Phe-OMe (8c) (0.065 g, 0.115 mmol), Pd(OAc)2 (2.6 mg, 0.012 mmol, 10 
mol%), AgOAc (0.096 g, 0.576 mmol) and styrene (0.063 mL, 0.461 mmol) were stirred 
together in t-amyl-OH (1 mL) at 130 °C for 12 h. The reaction was then allowed to cool to 
room temperature and filtered through a plug of Celite; the filtrate was then concentrated to 
dryness in vacuo. Examination of the 1H NMR spectrum for the crude product indicated that 
11 was the only modified peptide in the residue. Purification by flash column 
chromatography (30% EtOAc/pet. ether) gave modified peptide 11 as a yellow oil (0.043 g, 
49%); Rf 0.35 (30% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) δ 1.04-1.06 (18H, d, J = 7.6, TIPS-(CH3)2 (x3)), 1.55-1.63 (3H, m, 
TIPS-CH (x3)), 1.83 (3H, s, acetyl-CH3), 3.16 (2H, br d, J = 6.0, Phe-CH2), 3.28 (1H, dd, J = 
14.2, J = 8.1, Trp-CHH), 3.39 (3H, s, ester-CH3), 3.46 (1H, dd, J = 14.2, J = 6.3, Trp-CHH), 
4.61-4.72 (2H, m, Phe-α-CH / Trp-α-CH), 6.05 (1H, br d, J = 8.1, Trp-NH), 6.44 (1H, br d, J = 
7.2, Phe-NH), 6.99-7.10 (5H, m, alkene-CH / Ar-H), 7.26-7.32 (2H, m, Ar-H), 7.36-7.42 (5H, 
m, Ar-H), 7.46-7.54 (4H, m, alkene-CH / Ar-H), 7.56-7.62 (6H, m, Ar-H).  
13C{1H} NMR (100 MHz, CDCl3) δ 12.6 (TIPS-CH), 18.0 (TIPS-CH3), 23.1 (acetyl-CH3), 27.9 
(Trp-CH2), 31.7 (Phe-CH2), 52.5 (ester-CH3), 53.1 (Trp-α-CH), 53.8 (Phe-α-CH), 112.3 (Ar-
C), 113.9 (Ar-C), 118.4 (Ar-C), 119.7 (Ar-C), 121.5 (Ar-C), 125.5 (Ar-C), 126.0 (alkene-C), 
126.8 (Ar-C), 127.5 (Ar-C), 127.8 (Ar-C), 128.7 (Ar-C), 129.8 (Ar-C), 131.0 (Ar-C), 131.6 (Ar-
C), 131.8 (alkene-C), 137.2 (Ar-C), 137.8 (Ar-C), 141.1 (Ar-C), 169.9 (C=O), 170.8 (C=O), 
171.4 (C=O).  
IR Umax /cm-1 (oil) 3249 m (N-H), 3058 w (C-H), 2948 w (C-H), 2866 w (C-H), 1743 s (ester 
C=O), 1629 m (amide C=O), 1508 m (C=C), 1211 s (C-O).  



























Pd(OAc)2 (10 mol %)
AgOAc (5 eq), air
t-amylOH (0.12 M)
130 °C, 12 h
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3.9.7. Synthesis of Ac-Gly-(N-Me)Phe-Trp-OMe (12) 
Boc-(N-Me)-Phe-Trp-OMe (SI-19) 
 
Tryptophan methyl ester hydrochloride (0.637 g, 2.50 mmol) and K2CO3 (0.498 g, 3.60 
mmol) were dissolved in distilled water (30 mL) and stirred for 10 min at room temperature. 
The free amine was then extracted with CH2Cl2 (3 x 20 mL). The combined organics were 
dried (MgSO4) and the solvent removed in vacuo. The resulting yellow oil was dissolved in 
CH2Cl2 (30 mL) and treated with Boc-(N-Me)-phenylalanine (0.279 g, 1.00 mmol), i-Pr2NEt 
(0.174 mL, 1.00 mmol) and HATU (0.380 g, 1.00 mmol). The reaction mixture was stirred for 
12 h, and then diluted with CH2Cl2 (30 mL) The organic phase was washed with 1 M HCl (20 
mL), sat. NaHCO3 (3 x 20 mL) and H2O (20 mL), and then dried (MgSO4) and the solvent 
removed in vacuo. Purification by flash column chromatography (80% EtOAc/pet ether), 
followed by recrystallisation from CH2Cl2 / hexanes gave SI-19 as a cream solid (0.353 g, 
74%); m.p. 71-73 °C, Rf 0.24 (80% EtOAc/pet. ether). 
1H NMR (400 MHz, CDCl3) The spectrum contained a mixture of rotamers in the ratio 11:9. 
major rotamer: δ 1.20 (9H, s, Boc-(CH3)3), 2.41 (3H, s, N-CH3), 2.75-2.85 (1H, m, Phe-CHH), 
3.19-3.40 (3H, m, Phe-CHH / Trp-CH2), 3.68 ( 3H, s, ester-CH3), 4.69 (1H, br d, J = 7.8, Phe-
a-CH), 4.80-4.90 (1H, m, Trp-a-CH), 6.40 (1H, d, J = 6.5, Trp-NH), 6.88 (1H, s, Ar-H), 7.03-
7.34 (8H, m, Ar-H), 7.52 (1H, d, J = 7.8, Ar-H), 8.81 (1H, br s, Trp-Ar-NH); 
minor rotamer δ 1.30 (9H, s, Boc-(CH3)3), 2.43 (3H, s, N-CH3), 2.86-2.97 (1H, m, Phe-CHH), 
3.19-3.40 (3H, m, Phe-CHH / Trp-CH2), 3.60 ( 3H, s, ester-CH3), 4.80-4.90 (2H, m, Trp-a-CH 
/ Phe-a-CH), 6.65 (1H, d, J = 6.2, Trp-NH), 6.92 (1H, s, Ar-H), 7.03-7.34 (8H, m, Ar-H), 7.52 
(1H, d, J = 7.8, Ar-H), 8.77 (1H, br s, Trp-Ar-NH). 
13C{1H} NMR (100 MHz, CDCl3)  
minor rotamer: δ 27.3 (Trp-CH2), 27.8 (Boc-(CH3)3), 30.8 (N-CH3), 33.6 (Phe-CH2), 52.3 












118.0 (Ar-C), 119.5 (Ar-C), 122.0 (Ar-C), 122.7 (Ar-C), 126.3 (Ar-C), 127.0 (Ar-C), 128.3 (Ar-
C), 128.7 (Ar-C), 136.1 (Ar-C), 137.6 (Ar-C), 154.9 (C=O), 170.0 (C=O), 172.1 (C=O); 
minor rotamer: δ 27.3 (Trp-CH2), 27.9 (Boc-(CH3)3), 30.2 (N-CH3), 33.8 (Phe-CH2), 52.2 
(ester-CH3), 53.0 (Trp-α-CH), 59.6 (Phe-α-CH), 80.2 (Boc-C), 109.3 (Ar-C), 111.2 (Ar-C), 
118.1 (Ar-C), 119.3 (Ar-C), 121.9 (Ar-C), 122.7 (Ar-C), 126.2 (Ar-C), 127.3 (Ar-C), 128.2 (Ar-
C), 128.7 (Ar-C), 136.0 (Ar-C), 137.2 (Ar-C), 156.1 (C=O), 170.5 (C=O), 172.1 (C=O). 
IR Umax /cm-1 (solid) 3316 w (N-H), 3028 w (C-H), 2954 w (C-H), 1739 m (ester C=O), 1664 s 
(amide C=O), 1507 m (C=C), 1211 m (C-O). 





Boc-(N-Me)-Phe-Trp-OMe (SI-19) (0.320 g, 0.667 mmol) was stirred in a solution of 20% 
trifluoroacetic acid in CH2Cl2 (7.5 mL). Subsequently, the volatiles were removed in vacuo 
and the resulting residue was dissolved in EtOAc (50 mL). This solution was then washed 
with sat. NaHCO3 (25 mL), dried (MgSO4) and concentrated to dryness. The resulting amine 
was dissolved in DMF (5 mL), and treated with N-acetyl glycine (0.078 g, 0.667 mmol), NEt3 
(0.186 mL, 1.334 mmol) and HATU (0.304 g 0.800 mmol). The reaction mixture was stirred 
at room temperature for 18 h, before being quenched with sat. NaHCO3 (5 mL) and stirred 
for a further 30 min. The reaction mixture was then diluted with H2O (50 mL) and extracted 
with EtOAc (2 x 50 mL). The combined organics were dried (MgSO4) and the solvent 
removed in vacuo. The crude, yellow oil was purified by flash column chromatography 
(EtOAc) and recrystallised from CH2Cl2 / hexanes to give SI-20 as an off-white solid. (0.198 















1H NMR (400 MHz, CDCl3) δ 1.96 (3H, s, acetyl-CH3), 2.33 (3H, s, N-CH3), 2.82-2.87 (1H, m 
Phe-CHH), 3.11 (1H, dd, J = 14.6, 8.5, Trp-CHH), 3.20 (1H, dd, J = 14.6, 6.2, Phe-CHH), 
3.37 (1H, dd, J = 14.6, 5.0, Trp-CHH), 3.44 (1H, dd, J = 17.6, 3.7, Gly-CHH), 3.71 (3H, s, 
ester-CH3), 3.78 (1H, dd, J = 17.6, 5.5, Gly-CHH), 4.84-4.92 (1H, m, Trp-a-CH), 5.29-5.37 
(1H, m, Phe-a-CH), 6.45 (1H, t, J = 4.6, Gly-NH), 6.57 (1H, d, J = 7.8, Trp-NH), 6.87 (1H, d, 
J = 2.3, Ar-H), 7.02-7.10 (3H, m, Ar-H), 7.12-7.22 (4H, m, Ar-H), 7.34 (1H, d, J = 8.2, Ar-H), 
7.51 (1H, d, J = 7.8, Ar-H), 9.03 (1H, s, Trp-Ar-NH). 
13C{1H} NMR (100 MHz, CDCl3) δ 22.8 (acetyl-CH3), 27.2 (Trp-CH2), 29.5 (N-CH3), 33.4 
(Phe-CH2), 40.9 (Gly-CH2), 52.1 (Trp-α-CH), 52.4 (ester-CH3), 57.2 (Phe-α-CH), 109.3 (Ar-
C), 111.3 (Ar-C), 118.2 (Ar-C), 119.4 (Ar-C), 122.1 (Ar-C), 123.1 (Ar-C), 126.6 (Ar-C), 127.0 
(Ar-C), 128.4 (Ar-C), 128.5 (Ar-C), 136.0 (Ar-C), 136.5 (Ar-C), 169.2 (C=O), 169.2 (C=O), 
170.5 (C=O), 172.2 (C=O). 
IR Umax /cm-1 (solid) 3299 m (N-H), 3058 w (C-H), 2954 w (C-H), 1735 m (ester C=O), 1636 s 
(amide C=O), 1522 m (C=C), 1210 m (C-O). 
HRMS (ESI) [M+H+] m/z calcd. For C26H31N4O5: 479.2294, found: 479.2300. 
Ac-Gly-(N-Me)-Phe-Trp(Boc)-OMe (12) 
 
Peptide 12 was synthesised from Ac-Gly-(N-Me)-Phe-Trp-OMe (0.198 g, 0.414 mmol) using 
the procedure in section 2.3. Purification by flash column chromatography (EtOAc) followed 
by recrystallisation from CH2Cl2 / hexanes gave 12 as a white solid (0.129 g, 54%); m.p. 63-
66 °C, Rf = 0.2 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.68 (9H, s, Boc-(CH3)3), 2.03 (3H, s, acetyl-CH3), 2.68 (3H, s, 
N-CH3), 2.93 (1H, dd, J = 14.6, 9.2, Phe-CHH), 3.17 (1H, dd, J = 15.1, 6.9, Trp-CHH), 3.22-
3.31 (2H, m, Phe-CHH / Trp-CHH), 3.58-3.70 (4H, m, ester-CH3 / Gly-CHH), 3.83 (1H, dd, J 
= 18.5, 4.4, Gly-CHH), 4.84-4.91 (1H, m, Trp-a-CH), 5.24 (1H, dd, J = 9.2, 6.9, Phe-a-CH), 
6.50 (1H, br s, Gly-NH), 6.58 (1H, d, J = 7.8, Trp-NH), 7.08-7.27 (6H, m, Ar-H), 7.31 (1H, t, J 















13C{1H} NMR (100 MHz, CDCl3) δ  22.9 (acetyl-CH3), 27.0 (Trp-CH2), 28.2 (Boc-(CH3)3), 30.2 
(N-CH3), 33.5 (Phe-CH2), 41.4 (Gly-CH2), 52.1 (Trp-α-CH), 52.5 (ester-CH3), 57.9 (Phe-α-
CH), 84.1 (Boc-C), 114.6 (Ar-C), 115.3 (Ar-C), 118.6 (Ar-C), 122.5 (Ar-C), 124.3 (Ar-C), 
124.6 (Ar-C), 126.8 (Ar-C), 128.6 (Ar-C), 128.7 (Ar-C) 128.9 (Ar-C), 130.4 (Ar-C), 136.4 (Ar-
C), 149.7 (C=O), 169.2 (C=O), 169.4 (C=O), 170.0 (C=O), 171.6 (C=O). 
IR Umax /cm-1 (solid) 3319 w (N-H), 3060 w (C-H), 2953 m (C-H), 1730 s (ester C=O), 1638 s 
(amide C=O), 1522 s (C=C), 1254 (C-O). 
HRMS (ESI) [M+H+] m/z calcd. For C31H39N4O7: 579.2819, found: 579.2816. 
  
S72 
3.9.8. C-H olefination of Ac-Gly-(N-Me)-Phe-Trp(Boc)-OMe (12); synthesis of 
modified peptide 13 
 
Modified peptide 13 was prepared from Ac-Gly-(N-Me)-Phe-Trp(Boc)-OMe (8c) (0.129 g, 
0.223 mmol) and styrene (0.103 mL, 0.892 mmol), using the general procedure in section 
2.4. Purification by flash column chromatography (EtOAc) followed by recrystallisation from 
CH2Cl2 / hexanes gave 13 as a yellow solid (0.084 g, 55%); m.p. 94-98 °C, Rf 0.28 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.64 (9H, s, Boc(CH3)3), 1.97 (3H, s, acetyl-CH3), 2.41 (3H, s, 
N-CH3), 2.85 (1H, dd, J = 14.6, 9.8, Phe-CHH), 3.16 (1H, dd, J = 14.7, 6.3, Phe-CHH), 3.24 
(1H, dd, J = 14.4, 8.6, Trp-CHH), 3.40 (1H, dd, J = 14.4, 6.4, Trp-CHH), 3.52 (1H, dd, J = 
17.7, 3.4, Gly-CHH), 3.62 (3H, s, ester-CH3), 3.67 (1H, dd, J = 17.9, 4.5, Gly-CHH), 4.93-
5.01 (1H, m, Trp-a-CH), 5.23 (1H, dd, J = 9.6, 6.4, Phe-a-CH), 6.29 (1H, br s, Gly-NH), 6.45 
(1H, d, J = 8.0, Trp-NH),  6.77 (1H, d, J = 16.7, alkene-CH), 7.00-7.10 (2H, m, Ar-H), 7.12-
7.24 (4H, m, Ar-H), 7.27-7.41 (5H, m, Ar-H / alkene-CH), 7.51 (1H, d, J = 7.8, Ar-H), 7.56 
(2H, d, J = 7.9, Ar-H), 8.11 (1H, d, J = 8.8, Ar-H); 
13C{1H} NMR (100 MHz, CDCl3) δ 22.9 (acetyl-CH3), 27.5 (Trp-CH2), 28.3 (Boc-(CH3)3), 29.7 
(N-CH3), 33.5 (Phe-CH2), 41.4 (Gly-CH2), 52.0 (Trp-CH), 52.6 (ester-CH3), 57.6 (Phe-CH), 
84.3 (Boc-C), 114.5 (Ar-C). 115.6 (Ar-C), 118.5 (Ar-C), 120.0 (alkene-C), 122.9 (Ar-C), 124.9 
(Ar-C), 126.6 (Ar-C), 126.8 (Ar-C), 128.1 (Ar-C), 128.6 (Ar-C), 128.6 (Ar-C), 128.8 (Ar-C), 
130.0 (Ar-C), 132.2 (alkene-C), 135.7 (Ar-C), 136.2 (Ar-C), 136.4 (Ar-C), 136.7 (Ar-C), 150.4 
(C=O), 169.2 (C=O), 169.2 (C=O), 169.8 (C=O), 172.0 (C=O); 
IR Umax /cm-1 (solid) 3275 w (N-H), 3058 w (C-H), 2976 w (C-H), 1728 s (ester C=O), 1634 s 
(amide C=O), 1541 m (C=C), 1237 s (C-O); 
















3.10. Investigation of potential racemization in the C-H olefination reaction 
For the synthesis of modified peptides that contained more than one stereogenic centre, 
there was no evidence for the formation of diastereomeric products, as judged by NMR 
spectroscopy.  
In addition, a detailed stereochemical investigation was carried out for the reaction of peptide 
Ac-Ala-Trp(Boc)-OMe (4a) to give modified peptide 5a. Specifically, the diastereomeric 
peptide Ac-Ala-ᴅ-Trp(Boc)-OMe (SI-22), prepared from ᴅ-tryptophan methyl ester and 
acetyl-ʟ-alanine, followed by Boc protection of the ᴅ-Trp residue, was modified to give the 
diastereomeric modified peptide SI-23. 
Comparison of the HPLC chromatograms revealed that the modified peptide 5a contained 
ca. 0.1% of the diastereomeric peptide SI-23.  
The relevant synthetic procedures, characterisation data, and comparison of HPLC 






Ac-Ala-D-Trp-OMe (SI-21) was synthesised from D-tryptophan methyl ester hydrochloride 
(0.637 g, 2.50 mmol) and N-acetylalanine (0.131 g, 1.00 mmol), using the procedure in 
section 2.1. The crude compound was washed with CH2Cl2 to afford SI-21 as a white solid 









































1H NMR (400 MHz, CDCl3) δ 1.22 (3H, d, J = 7.1, Ala-CH3), 1.84 (3H, s, acetyl-CH3), 3.30 
(2H, d, J = 6.0, Trp-CH2), 3.67 (3H, s, ester-CH3), 4.38-4.47 (1H, m, Ala-a-CH), 4.83 (1H, dt, 
J = 6.0, 6.0, Trp-a-CH), 6.36 (1H, d, J = 7.3, Ala-NH), 6.95-7.02 (2H, m, Trp-NH, Ar-H), 7.09 
(1H, t, J = 7.5, Ar-H), 7.16 (1H, t, J = 7.6, Ar-H), 7.32 (1H, d, J = 8.0, Ar-H), 7.52 (1H, d, J = 
7.8, Ar-H), 8.60 (1H, br s, Trp-Ar-NH). 
13C{1H} NMR (100 MHz, CDCl3) δ 18.3 (Ala-CH3), 23.0 (acetyl-CH3), 27.3 (Trp-CH2), 48.7 
(Ala-a-CH), 52.4 (ester-CH3), 52.9 (Trp-a-CH), 109.5 (Ar-C), 111.4 (Ar-C), 118.3 (Ar-C), 
119.5 (Ar-C), 122.1 (Ar-C), 123.1 (Ar-C), 127.4 (Ar-C), 136.1 (Ar-C), 170.1 (C=O), 172.2 
(C=O), 172.3 (C=O). 
IR Umax /cm-1 (solid) 3239 m (N-H), 3060 s (C-H), 2976 m (C-H), 1742 s (ester C=O), 1641 s 
(amide C=O), 1541 s (C=C), 1217 s (C-O). 




Diastereomeric peptide SI-22 was synthesised from Ac-Ala-D-Trp-OMe (0.205 g, 0.62 mmol) 
using the procedure in section 2.3. Purification by flash column chromatography (EtOAc) 
followed by recrystallisation from CH2Cl2 / hexanes gave SI-22 as a white solid (0.105 g, 
88%); m.p. 181-183 °C, Rf 0.2 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.30 (3H, d, J = 7.1, Ala-CH3), 1.66 (9H, s, Boc-(CH3)3), 1.96 
(3H, s, acetyl-CH3), 3.20 (1H, dd, J = 14.9, 6.1, Trp-CHH), 3.28 (1H, dd, J = 14.9, 5.6, Trp-
CHH), 3.69 (1H, s, ester-CH3), 4.45-4.53 (1H, m, Ala-a-CH), 4.89 (1H, dt, J = 6.1, 5.6, Trp-a-
CH), 6.19 (1H, d, J = 7.6, Ala-NH), 6.79 (1H, d, J = 7.6, Trp-NH), 7.23 (1H, t, J = 7.6, Ar-H), 
7.31 (1H, t, J = 7.3, Ar-H), 7.39 (1H, s, Ar-H), 7.48 (1H, d, J = 7.8, Ar-H), 8.11 (1H, br. d, J = 
7.3, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 18.5 (Ala-CH3), 23.1 (acetyl-CH3), 27.2 (Trp-CH2), 28.2 












C), 115.3 (Ar-C) 118.7 (Ar-C), 122.6 (Ar-C), 124.2 (Ar-C), 124.6 (Ar-C), 130.3 (Ar-C), 135.3 
(Ar-C), 149.5 (C=O), 169.9 (C=O), 171.7 (C=O), 172.0 (C=O). 
IR Umax /cm-1 (solid) 3278 w (N-H), 3071 w (C-H), 2978 w (C-H), 1730 s (ester C=O), 1640 s 
(amide C=O), 1530 (C=C), 1254 (C-O). 
HRMS (ESI) [M+H+] m/z calcd. for C22H30N3O6: 432.2135, found: 432.2132. 
 
Synthesis of modified peptide SI-23 
 
Diastereomeric, modified peptide SI-23 was prepared from Ac-Ala-D-Trp(Boc)-OMe (SI-22) 
(0.100 g, 0.232 mmol) and styrene (0.109 mL, 0.952 mmol), using the general procedure in 
section 2.4. Purification by flash column chromatography (EtOAc) followed by 
recrystallisation from CH2Cl2 / hexanes gave SI-23 as a brown solid (0.078 g, 61%); m.p. 
171-174 °C, Rf 0.26 (EtOAc). 
1H NMR (400 MHz, CDCl3) δ 1.12 (3H, d, J = 7.1, Ala-CH3), 1.62 (9H, s, Boc-CH3), 1.90 (3H, 
s, acetyl-CH3), 3.30 (1H, dd, J = 14.4, 7.3, Trp-CHH), 3.39 (1H, dd, J = 14.4, 6.7, Trp-CHH), 
3.56 (3H, s, ester-CH3), 4.40-4.50 (1H, m, Ala-a-CH), 4.89 (1H, app q, J = 7.4, Trp-a-CH), 
6.27 (1H, d, J = 7.6, Trp-NH), 6.79 (1H, d, J = 16.5, alkene-CH), 7.06 (1H, d, J = 8.2, Ala-
NH), 7.20-7.33 (4H, m, Ar-H), 7.35-7.40 (2H, m, alkene-CH/Ar-H), 7.55 (2H, d, J = 7.3, Ar-
H), 7.60 (1H, d, J = 7.3, Ar-H), 8.12 (1H, d, J = 8.2, Ar-H). 
13C{1H} NMR (100 MHz, CDCl3) δ 18.0 (Ala-CH3), 23.0 (acetyl-CH3), 27.7 (Trp-CH2), 28.2 
(Boc-(CH3)3), 48.5 (Ala-a-CH), 52.4 (ester-CH3), 52.6 (Trp-a-CH), 84.0 (Boc-C), 114.8 (Ar-
C), 115.5 (Ar-C), 118.7 (Ar-C), 120.0 (alkene-CH),122.8 (Ar-C),124.7 (Ar-C), 126.5 (Ar-C), 
127.9 (Ar-C), 128.7 (Ar-C), 130.0 (Ar-C), 132.3 (alkene-CH), 135.8 (Ar-C), 136.0 (Ar-C), 
136.8 (Ar-C), 150.3 (C=O), 169.9 (C=O), 172.0 (C=O), 172.1 (C=O). 
IR Umax /cm-1 (solid) 3058 w (C-H), 2978 w (C-H), 1728 s (ester C=O), 1634 s (amide C=O), 
1541 m (C=C), 1272 m (C-O).  













HPLC- chromatogram and ES-MS for peptide 4a. 
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HPLC-chromatogram and ES-MS for modified peptide 5a.  
 




9.774; 99.886%. ; .
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5. 1H and 13C NMR spectra of compounds 1-13 
1H NMR spectrum (400 MHz, CD3OD) of 1a 
 



















1H NMR spectrum (400 MHz, CDCl3) of 1b 
 




















1H NMR spectrum (400 MHz, CDCl3) of 2b 
 
 





















1H NMR spectrum (400 MHz, CDCl3) of 2b’ 
 























1H NMR spectrum (400 MHz, CDCl3) of 3a 
 





















1H NMR spectrum (400 MHz, CDCl3) of 3b 
 
 





















1H NMR spectrum (400 MHz, CDCl3) of 3c 
 
 






















1H NMR spectrum (400 MHz, CDCl3) of 3d 
 





















1H NMR spectrum (400 MHz, CDCl3) of 3e 
 






















1H NMR spectrum (400 MHz, CDCl3) of 3f 
13C{1H} NMR spectrum (100 MHz, CDCl3) of 3f 
  
AH142_C2_S1_PROTON-2-1.jdf



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1H NMR spectrum (400 MHz, CDCl3) of 4a 
 
13C{1H} NMR spectrum (100 MHz, CDCl3) of 4a 
  
AH104_redo_CARBON-1-1.jdf




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1H NMR spectrum (400 MHz, CDCl3) of 4b 
 
 





















1H NMR spectrum (400 MHz, CDCl3) of 4c 
 






















1H NMR spectrum (400 MHz, CDCl3) of 4d 
 
 





















1H NMR spectrum (400 MHz, CDCl3) of 4e 
 























1H NMR spectrum (400 MHz, CDCl3) of 4f  
 


























1H NMR spectrum (400 MHz, CDCl3) of 4g 
 


























1H NMR spectrum (400 MHz, CDCl3) of 4h  
 



























1H NMR spectrum (400 MHz, CDCl3) of 4i  
 































1H NMR spectrum (400 MHz, CD3OD) of 4j  
 



























1H NMR spectrum (400 MHz, CDCl3) of 5a 
 
 


























1H NMR spectrum (400 MHz, CDCl3) of 5b 
 





















1H NMR spectrum (400 MHz, CDCl3) of 5c 
 


























1H NMR spectrum (400 MHz, CDCl3) of 5d  
 




















1H NMR spectrum (400 MHz, CDCl3) of 5e  
 



























1H NMR spectrum (400 MHz, CDCl3) of 5f  
 




























1H NMR spectrum (400 MHz, CDCl3) of 5g  
 

























1H NMR spectrum (400 MHz, CDCl3) of 5h 
 



























1H NMR spectrum (400 MHz, CDCl3) of 5i 
 

































1H NMR spectrum (400 MHz, CDCl3) of 5j  
 





























1H NMR spectrum (400 MHz, CDCl3) of 6 
 















1H NMR spectrum (400 MHz, CDCl3) of 7 
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